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Abstract 
 
 The primary purpose of this thesis was to examine the validity and reproducibility 
of the QT-variability index (QTVI) as a measure of cardiac autonomic function in 
individuals with spinal cord injury (SCI). The secondary purpose was to investigate the 
influence of cardiac autonomic activity and blood volume on diastolic function in 
individuals with SCI. Results from Study 1 showed that the QTVI increased when 
participants performed a cardiovascular (CV) stress maneuver, and subsequently returned 
to baseline after blocking sympathetic outflow via metoprolol. Moreover, while 
participants were resting, the QTVI increased after blocking parasympathetic activity via 
atropine. These results suggest that the QTVI may reflect both cardiac sympathetic and 
parasympathetic activity in those with incomplete SCI, depending on the autonomic state 
of the individual.  Results from Study 2 demonstrate high day-to-day reproducibility of 
the QTVI in participants with SCI, regardless of injury level, and also in those with high 
level injuries who may have reduced cardiac sympathetic regulation. Results from Study 
3 showed that indices of cardiac parasympathetic activity (HRV and QTVI) were 
correlated with left ventricular filling in able-bodied individuals but not in individuals 
with SCI, suggesting a disconnect between cardiac parasympathetic activity and diastolic 
function after SCI. In addition, for the able-bodied group, the cold face test (CFT) 
increased vagal activity which was associated with bradycardia and augmentation of 
diastolic filling. However, for the SCI group, the increase in vagal activity during the 
CFT was associated with no change in heart rate and an attenuation of diastolic function. 
Results from Study 4 showed that although individuals with SCI were hypovolemic, 
resting diastolic velocities were similar compared to the able-bodied group. This 
 
 
maintenance of diastolic function appeared to be attributed to the cardiac atrophy that 
manifests following SCI. In addition, there was no between-group difference in the 
diastolic response to rapid saline infusion.  
Findings from this dissertation suggest that the QTVI is a valid and reliable tool 
for non-invasively estimating cardiac autonomic regulation in individuals with SCI. In 
addition, although the mechanical aspect of diastolic function is preserved after SCI, 
atypical vagal-diastolic interactions may impair ventricular filling in this population.     
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Chapter 1 – Introduction  
 
 The heart is arguably the most dynamic muscle in the body, which can be attributed 
to its intricate anatomical muscle fibre orientation, its ability to contract (and relax) in 
various directional planes of motion and the cascade of biochemical, electrical and 
mechanical events that are continuously occurring within it. In addition, cardiac structure 
and function are constantly influenced by a multitude of external factors such as vascular 
compliance, hemodynamic load, inflammation and neuro-hormonal activation1. All of 
these aforementioned factors are required to operate synergistically in order for the heart 
to function in an appropriate manner. Although the cardiovascular system is a combination 
of various physiological systems, it still operates as one entity via positive and negative 
feedback loops. As such, altered activity in any of the stated factors can result in cardiac 
maladaptation. It is important to note that “cardiac system” refers to the heart per se, 
whereas the “cardiovascular system” refers to the heart and vasculature.  
 Spinal cord injury (SCI) is a condition that typically leads to dysfunctions in most 
physiological systems in the body. These dysfunctions can be a direct consequence of the 
SCI itself, as is the case for motor and sensory paralysis, or they can be due to the symptoms 
arising from SCI, such as pressure ulcers and metabolic disorders. This thesis however, 
focuses on the cardiac system and how it is influenced by SCI. More specifically, this thesis 
explores two aspects of the cardiac system following SCI; the first being cardiac autonomic 
function and the second being diastolic function. In addition, the interaction between 
autonomic and diastolic function in those with SCI will also be examined.   
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 Regarding cardiac autonomic activity, the heart is normally under the constant 
influence of both the parasympathetic and sympathetic nervous systems2. However, due to 
spinal damage following SCI, there is a loss, or a reduction, of supraspinal control of the 
heart, thus attenuating cardiac autonomic regulation. Accordingly, an important question 
in the field of SCI research is: Is there a valid, reliable and non-invasive tool that will allow 
us to measure the amount of preserved cardiac autonomic function in humans with SCI? 
Having such a tool would be of substantial clinical value, as it could improve our ability to 
diagnose and track autonomic dysfunctions after SCI. This tool could also be used for the 
assessment of cardiovascular risk, and it could allow researchers to monitor autonomic 
responses to treatments and interventions. The electrocardiogram (ECG) is a non-invasive 
tool that reflects global cardiac electrical activity, and since cardiac electrical activity is 
highly modulated by autonomic activity, the ECG may be used as an indirect index of 
autonomic function. Traditional ECG-based measures of cardiac autonomic activity 
include frequency and time-domain measures of beat-to-beat temporal variability, known 
as heart rate variability (HRV). However, certain aspects of HRV have their limitations, as 
the physiological basis of some HRV parameters do not necessarily correlate with cardiac 
autonomic activity in able-bodied individuals3 or those with SCI4. The QT-variability index 
(QTVI) is a relatively new, ECG-based, measure of beat-to-beat repolarization variability. 
Recent animal studies have demonstrated correlations between the QTVI and cardiac 
sympathetic and parasympathetic outflow5. However, the relationship between the QTVI 
and cardiac autonomic activity in humans remains unclear and warrants further 
investigation as it may hold promise as a means of gauging cardiac autonomic function in 
individuals with SCI. Therefore, the first two manuscripts of this thesis will focus on 
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examining the validity and reliability of the QTVI as a measure of cardiac autonomic 
activity in those with SCI. 
 To date, findings regarding left ventricular diastolic function following SCI are 
equivocal, as some studies have shown reduced diastolic function6,7 whereas others showed 
that it is preserved8,9. From a cardiac pathophysiological perspective, impaired diastolic 
function suggests an increase in left ventricular stiffness and reduced compliance due to 
fibrosis, which impairs the ventricle’s ability to rapidly fill with blood, and causes an 
elevation in ventricular filling pressure for a given blood volume10. However, individuals 
with SCI do not typically display co-morbidities that lead to increased myocardial fibrosis, 
such as hypertension. Therefore, it is quite possible that the purported impairments in 
diastolic function following SCI are not a result of fibrotic or diseased ventricles, but could 
be due to other systemic changes that take place after SCI, specifically changes in cardiac 
parasympathetic activity and reduced preload.  
Experimental studies have shown, via both vagal stimulation13 and withdrawal14, 
that parasympathetic activity may play a role in modulating diastolic function. Specifically, 
increased vagal activity may improve ventricular filling. In support of these findings, 
diastolic impairments have been reported to be more severe in individuals with lower 
cardiac parasympathetic outflow in both healthy11 and diseased12 able-bodied populations. 
Furthermore, diastolic function is highly influenced by preload as an increase in venous 
return results in elevated left atrial filling, thus increasing atrial pressure and resulting in 
higher diastolic filling velocities. Alterations in both these factors (parasympathetic activity 
and preload) are typically manifested after SCI, such that a reduction in parasympathetic 
activity (due to physical inactivity), and reduced preload (due to hypovolemia and an 
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ablation of the muscle pump effect) are typically observed. Accordingly, it is quite possible 
that the putative diastolic impairments in those with SCI are a result of either a reduced 
cardiac vagal activity or a reduced preload, or a combination of the two. Therefore, the last 
two manuscripts of this thesis will examine the relationship between cardiac vagal activity 
and diastolic function, as well as the influence of preload on diastolic function, in 
individuals with SCI.         
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Chapter 2 – Literature Review 
 
Etiology of Spinal Cord Injury 
 
SPINAL CORD INJURY (SCI) is a particularly abrupt and life altering neuromuscular 
condition. It can have detrimental physiological, psychological and social impacts on the 
individual. The main pathology of SCI involves death of neural tissue within the spinal 
cord, thus obscuring supraspinal signals from reaching their target organs to perform 
normal bodily functions. This can result in motor paralysis, autonomic dysfunctions and 
sensory malfunction. Some of these dysfunctions manifest immediately after an injury, 
while others develop chronically over time. Spinal cord tissue damage can occur from 
traumatic or non-traumatic causes. Traumatic SCI occurs when an external physical impact 
damages the spinal cord either directly, or by crushing the vertebral column around the 
spinal cord or by reducing blood supply to the spinal cord. In contrast, non-traumatic SCI 
can result from infection, disease or radiation that causes neural tissue necrosis. The 
resultant spinal cord damage from the initial injury is called the primary injury, which leads 
to localized and often small spinal damage. However, within hours to approximately a 
month after the initial trauma, the secondary injury phase occurs, whereby the site of injury 
starts to expand due to inflammation, ischemia and ion degradation (See Figure 1).  
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Figure 1: Spinal Cord Injury 
 
 
 
 
 
 
 
It is the secondary damage that causes the majority of complications following an injury 
due to the increased neural tissue death. Immediately after a SCI, the individual experiences 
both spinal shock and neurogenic shock. Spinal shock is a temporary period of complete 
motor, and often sensory, paralysis below the level of injury. This period lasts for 
approximately a week until the individual starts to regain some function, which may be 
attributed to spontaneous regeneration or myelination of neural tissue. Neurogenic shock 
on the other hand is complete ablation of autonomic regulation, which is characterized by 
dangerously low blood pressure and uncontrolled cardiac arrhythmias. Neurogenic shock 
also dissipates within approximately a week after an injury, however, this is the time period 
when other autonomic dysfunctions, such as autonomic dysreflexia, start to manifest. 
Animal studies have shown that axons undergo severe atrophy during the neurogenic shock 
stage, but regain their size and arborisation at approximately the same time as when 
autonomic regulation starts to work again. As axonal size and arborisation is regained, there 
Myelinated Neuron 
Primary Injury Secondary Injury 
Astrocyte Scar 
Tissue 
Demyelinated Neuron 
Severed Neuron 
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is a concomitant manifestation of autonomic dysreflexia however, suggesting inappropriate 
neural connections are formed after the neurogenic shock period15.   
Figure 2: Axonal Morphology before and after Injury 
 
A: Normal axonal size and arborisation at baseline; B: Axonal atrophy and loss of 
arborisation immediately after SCI; C: Axonal size and arborisation regained after 4 weeks 
of SCI, concomitant with autonomic dysreflexia.  
 
Classifications of Spinal Cord Injury 
 
Spinal cord injury is classified according to three categories: level of injury, 
severity of injury and whether the injury is an upper or a lower motor neuron injury. 
Regarding level of injury, SCI that results in damage to the cervical spine (above T1) is 
called tetraplegia, which involves impaired sensory and/motor function in the upper limbs, 
trunk, pelvic area and lower limbs. An injury that inflicts damage below the cervical region 
is known as paraplegia, which involves impaired sensory and/motor function in the trunk, 
pelvic area and lower limbs. The severity of SCI is governed by its completeness. 
Anatomically, a complete SCI spans the whole width of the spinal cord thus not allowing 
any spared neurons to bypass the site of injury. An incomplete injury does not span the 
whole width of the spinal cord, resulting in some neurons to bypass the injury. With respect 
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to function, in a complete injury there is no sensory or motor function below the 
neurological level of injury, including the 4th and 5th sacral dermatomes and myotomes. In 
an incomplete injury, there is spared motor and/or sensory function below the neurological 
level of injury, including the 4th and 5th sacral dermatomes and myotomes. A more accurate 
way to assess the level of completeness is by the ASIA (American Spinal Injury 
Association) impairment scale (AIS) (Appendix A). In order to assign an individual with 
an AIS score, the neurological level of injury needs to be established (See Appendix B) 
using motor (See Appendix C) and sensory (See Appendix D) examinations. Finally, an 
upper motor neuron injury refers to an injury to the central nervous system (spinal cord) 
whereas a lower motor neuron injury refers to an injury to the peripheral nerves.  
Epidemiology of Spinal Cord Injury 
 
 The incidence rate of SCI in Canada is estimated to be approximately 4259 new 
cases each year. Of this, an estimated 42% (1785) are the result of traumatic SCI, whereas 
58% are from non-traumatic causes. The prevalence rate of SCI in Canada is estimated to 
be 85,556 individuals living with SCI. Of this total, 51% (43,974) are the result of traumatic 
causes and 49% are from non-traumatic incidents16. Most injuries are acquired during 
young adulthood, between ages of 18-29 and are mostly due to motor vehicle accidents, 
sports or violence17. A second peak of acquired injuries takes place during old age (70 years 
and older) due to falls17. In Canada, the incidence of injuries according to spinal segments 
are as follows: 29% cervical, 21% thoracic and 50% lumbosacral18.  
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Autonomic Control of the Cardiovascular System 
 
Normal autonomic control of the cardiovascular (CV) system is executed through 
the constant balance of the sympathetic (SNS) and parasympathetic nervous systems 
(PNS)2. In general, both systems operate in opposing manners, the SNS is involved in the 
fight or flight response, such as increasing heart rate (HR), cardiac contractility and blood 
pressure. In contrast, the PNS is involved in maintaining resting state, such as reducing 
HR. The efferent pathways of both the SNS and PNS originate in the central nervous 
system, where neural messages pass from the preganglionic neurons through the autonomic 
ganglia, towards the post ganglionic neurons which then reach the target organ.  
Sympathetic Cardiovascular Function 
 
The neuroanatomy of cardiovascular sympathetic control consists of short 
sympathetic preganglionic neurons that originate in the lateral horn of the grey matter and 
exit the spinal cord through the thoracic and upper lumber spinal segments (T1-L2)19. 
The sympathetic preganglionic neurons between T1-T6 synapse with the sympathetic 
chain ganglia which then synapse with the long postganglionic neurons. The post 
ganglionic neurons release catecholamines into the effector organ, being the heart in this 
case in order to increase HR and ventricular contractility. Therefore, cardiac sympathetic 
activity is regulated via sympathetic spinal nerves of T1-T620. Sympathetic preganglionic 
nerves below the T6 spinal segment bypass the sympathetic chain and synapse with 
collateral ganglia, which then synapse with postganglionic neurons of the abdomen and 
pelvis in order to form the splanchnic nerves. Therefore, sympathetic spinal nerves 
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between T7-L2 play a critical role in regulating blood pressure though their influence on 
the splanchnic vascular bed19 (See Figure 3).  
Figure 3: Cardiovascular Sympathetic Regulation                 
 
The SNS mainly exerts its effects through the catecholamines epinephrine and 
norepinephrine. In order to increase HR and ventricular contractility, signals from 
supraspinal structures such as the rostural ventral medulla and raphe padillus relay 
excitatory signals to the dorsomedial hypothalamus. These supraspinal signals will 
descend via the brainstem down the spinal cord and exit from T1-T6, where the 
corresponding postganglionic neurons will release norepinephrine into the sino-atrial 
node in the right atrium19. Norepinephrine will bind onto β-1 adrenoceptors in the sino-
atrial node membrane which will increase the rate of early depolarization, causing the 
threshold membrane to be reached faster, which creates more rapid action potentials and 
thus increasing HR (See Figure 4).  
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Figure 4: Influence of Autonomic Activity on Rate of Action Potential Generation 
a: rapid rate of early depolarization from sympathetic activity on the sino-atrial node; b: 
slow rate of early depolarization and hyperpolarization from vagal influence on sino-
atrial node.  
 
In addition, norepinephrine released from the T1-T6 post ganglionic neurons will bind 
directly onto the ventricular walls, causing an increase in calcium release, thereby 
forming more actin and myosin cross-bridges, which therefore increases myocardial 
contractility2. Furthermore, in order to increase blood pressure, the sympathetic 
postganglionic neurons between T7-L2 will release norepinephrine, which will bind onto 
the alpha-1 adrenoceptors of blood vessels in the splanchnic bed, causing smooth muscle 
contractions thereby elevating pressure.   
Parasympathetic Cardiovascular Function 
 
Cardiac parasympathetic activity is regulated through the vagus nerve (Cranial 
Nerve X). Unlike sympathetic nerves, the parasympathetic preganglionic neurons are long 
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and originate in the dorsal motor nucleus of the medulla oblongata and exit from the 
brainstem as the vagus nerve. The parasympathetic preganglionic neurons synapse with the 
terminal ganglia, which is connected to the short postganglionic neurons. The 
postganglionic neurons will exert their effect onto the effector organ, the heart, via the 
neurotransmitter acetylcholine (See Figure 5).   
Figure 5: Cardiac Vagal Regulation 
 
In order to reduce HR, acetylcholine will bind onto the β-1 receptors of the sino-atrial node, 
which will cause hyperpolarization and will slow down the early depolarization phase (See 
Figure 4). Through these mechanisms, the threshold potential is reached at a slower rate, 
thus resulting in slower generation of action potentials which therefore, results in a slower 
HR22.  
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Cardiovascular Autonomic Regulations after Spinal Cord Injury 
 
The severity of CV autonomic dysfunctions following SCI has been shown to be 
directly related to the level and completeness of the injury. As mentioned above, cardiac 
sympathetic function is regulated by spinal nerves between T1-T6, and caudal to that are 
the sympathetic nerves responsible for blood pressure regulation19. Therefore, cervical 
injuries, or high thoracic injuries, may result in the loss, or attenuation, of supraspinal 
regulation of HR and blood pressure. In addition, the attenuation of supraspinal 
regulation over the splanchnic bed can result in hypotension22, orthostatic hypotension23, 
and potentially dangerous reflexive fluctuations in blood pressure known as autonomic 
dysreflexia24.  In contrast, cardiac parasympathetic activity is not directly affected by the 
SCI, as the vagus nerve bypasses the spinal cord, and therefore cardiac parasympathetic 
innervation of the heart remains intact25. Such an imbalance in cardiac sympathetic and 
parasympathetic activity, however is associated with an increased risk of cardiac 
arrhythmias in individuals with SCI22. Thus, higher level injuries, specifically those 
above T1, are associated with a greater risk for cardiovascular autonomic dysfunction.  
Moreover, more complete injuries result in greater and more severe CV 
autonomic complications19. Histopathological examination of post-mortem spinal cord 
tissue showed that individuals with tetraplegia, who had severe CV abnormalities such as 
bradycardia, hypotension and autonomic dysreflexia, demonstrated more axonal 
degeneration, specifically white matter, compared to those with no or minor CV 
abnormalities26.   
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Electrocardiographic Measures of Cardiac Autonomic Activity 
 
 The electrocardiogram (ECG) provides an easy and non-invasive means of 
measuring the electrical activity of the heart.  Since cardiac electrophysiology and beat-
to-beat control of HR are tightly regulated by the autonomic nervous system27,28,29, ECG 
can be employed as an indirect index for assessing cardiac autonomic function. This 
section will discuss two ECG-based measures of cardiac autonomic function: heart rate 
variability (HRV) and the QT-variability index (QTVI).  
Heart Rate Variability 
 
Heart rate variability is an ECG-based measure of cardiac autonomic control that 
takes advantage of the normally occurring oscillations in beat-to-beat variability30. On a 
physiological basis, the parasympathetic system exerts its effects on the heart by releasing 
the neurotransmitter acetylcholine from the parasympathetic postganglionic neurons into 
the sino-atrial node, which decreases HR quickly (latencies to onset of 50-100 ms) and is 
also rapidly hydrolyzed by cholinesterase21,31. Therefore, due to the rapid activity of 
vagal influence on the heart, the parasympathetic system exerts its effects HR on a beat-
to-beat basis and thus, beat-to-beat temporal variability can be accounted for by 
parasympathetic activity. In contrast, the sympathetic system exerts its effects on the 
heart mainly through the hormone norepinephrine, which is released by the sympathetic 
postganglionic neurons (T1-T6) into the sino-atrial node. Unlike acetylcholine, 
norepinephrine exerts its effects to increase HR in a slow manner (1-3 seconds latency) 
but is also terminated slowly by the presynaptic reuptake and diffusion into the 
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surrounding extracellular fluids21,31. Therefore, due to the slow effects of the sympathetic 
system, it cannot influence HR on a beat-to-beat basis.  
Heart rate variability can be analyzed via time domain or frequency domain 
techniques. Time domain analysis of HRV involves mathematically computing the 
normal temporal variability that occurs between a given number of beats, some of these 
include standard deviation of all RR intervals (SDNN), root mean square of differences 
between RR intervals (RMSSD)32, and the coefficient of variance of a given number of 
RR intervals. Since time domain measures of HRV directly assess the amount of beat-to-
beat variability, they are believed to mainly reflect cardiac parasympathetic activity with 
some influence from sympathetic activity. Frequency domain analysis on the other hand 
is believed to provide a measure of both sympathetic and parasympathetic autonomic 
activity to the heart. In brief, successive RR intervals from an ECG (See Figure 6a) are 
plotted against time to create a tachogram (See Figure 6b) which is then analyzed through 
spectral density analysis. In resting healthy humans, successive RR intervals oscillate 
around 2 main frequencies: low frequency (LF; 0.04-0.15 Hz; centre frequency: 0.1 Hz) 
and high frequency (HF; 0.15-0.40 Hz; centre frequency: 0.25 Hz)33. The relative 
predominance, or power, of the LF and HF oscillations are then quantified and 
graphically represented in a power spectrum (See Figure 6c).  
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Figure 6a: Consecutive RR intervals on an ECG 
 
Figure 6b: Tachogram of RR intervals 
 
Figure 6c: Spectral high and low frequency of RR intervals  
        
a: Successive R-R intervals from an ECG recording; b: tachogram of the ECG recording; 
c: depiction of low frequency and high frequency ranges in healthy individuals.   
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The HF power portion of HRV reflects cardiac parasympathetic outflow as evidenced 
by its complete ablation after cholinergic blockade34,35 and following 
parasympathectomy36. The consensus on the physiological basis of LF power however 
remains debatable. It is generally considered that LF power reflects both autonomic limbs 
of the nervous system, since it has been shown to decrease in response to both cholinergic 
and β-blockers34. In addition, LF power was demonstrated to decrease by 50% after 
parasympathectomy, and an additional 20% reduction following administration of 
selective β-blocker36. However, others consider LF to be a poor marker of cardiac 
sympathetic activity, as LF has been shown to decrease after experimental coronary 
artery occlusion37 and after inducing congestive heart failure38, both of which typically 
result in elevated sympathetic activity.  
QT-Variability Index 
 
The QT interval of the ECG represents the duration of global myocardial 
repolarization. From an electrophysiological perspective, the QT interval temporally 
corresponds with the action potentials of all three myocardial layers. As shown in 
Appendix L, the endocardial layer is the first to repolarize in Phase 1, which takes place 
approximately at the same time as the Q-wave. The initial repolarization in Phase 1 is a 
result of the transient outward potassium current, however, the cell potential is 
maintained and plateaus during Phase 2 because of the inward calcium current. Phase 3 
represents myocardial repolarization which is driven by the outward movement of 
potassium ions carried by the rapid and slow delayed rectifier potassium currents. The 
sum of the transmural cardiac repolarization is represented by the T wave on the ECG. 
The initial ascending limb of the T wave is due to an increase in the transmural dispersion 
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between the ventricular layers, where an increase in the gradient results in an increase in 
electrical voltage. The epicardium is the first to fully repolarize, which corresponds with 
the T-peak on the ECG, while the mid myocardium is the last to repolarize, thus 
coinciding with the T-wave terminus39,40 (See Figure 7).  
 
Figure 7: Myocardial Repolarization and Electrocardiographic Activity.  
 
Phase 1: initial myocardial repolarization resulting from initial transient outward 
potassium movement which coincides with the J wave; Phase 2: myocardial 
repolarization plateau characterized by outward potassium movement and inward calcium 
influx; Phase 3: myocardial repolarization from transient outward potassium movement. 
Epicardial repolarization coincides with the T-wave peak and Mid myocardial 
repolarization coincides with the T-wave terminus.    
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 Similar to the RR interval, the QT interval displays a degree of variability on a beat-to-
beat basis. Such beat-to-beat repolarization variability can be calculated via the QTVI 
according the formula developed by Berger et al. (1997): 
QTVI = Log10 [(QTv/QTm
2) / (RRv/RRm2)] 
where, QTv is the QT interval variance, QTm2 is the mean QT interval squared, RRv is 
the RR interval variance and RRm2 is the mean RR interval squared41. Thus, QTVI 
values increase either due to an elevation in QT interval variance (numerator) or from a 
decrease in RR interval variance (denominator). Since both the QT and RR intervals are 
influenced by cardiac autonomic activity27,34,42, the QTVI may be a superior method of 
gauging cardiac autonomic activity compared to HRV, as it accounts for both intervals in 
its calculation. Experimental studies in healthy humans have shown that the QTVI 
increases when sympathetic activity is elevated, as demonstrated by CV stress maneuvers 
and infusion of the β-adrenoceptor agonist isoprotenerol43. Clinical studies have also 
shown that the QTVI is elevated in patients with conditions associated with elevated 
cardiac sympathetic activity such as hypertension44, heart failure45, dilated 
cardiomyopathy41 and anxiety46. These findings suggest that QTVI may be influenced by 
cardiac sympathetic activity. However, other investigators have also shown that the QTVI 
is elevated in situations that are associated with reduced vagal activity, such as healthy 
aging47 and cardiac autonomic neuropathy48. The most compelling evidence for the 
influence of cardiac autonomic activity on the QTVI was from Piccirillo et al.  (2009), 
who showed that during healthy resting conditions, QTVI was inversely related to 
integrated vagal nerve activity in dogs (r=-0.47; p=0.01). However, after ventricular 
pacing induced heart failure, the QTVI was directly associated with left stellate 
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ganglionic activity (r=0.57; p=0.01)5. This provides strong evidence that the QTVI is 
associated with cardiac sympathetic outflow during times of autonomic arousal, and is 
also inversely reflective of cardiac vagal outflow during resting conditions. In other 
words, it may reflect both autonomic limbs depending on the state the subject is in.   
Heart Rate Variability in Spinal Cord Injury 
 
 Heart rate variability has been employed for over two decades for the assessment 
of cardiac autonomic function in the SCI population. Although HRV has been shown to 
be reliable and reproducible in individuals with SCI49, the physiological basis of this 
measure remains somewhat equivocal, especially pertaining to the interpretation of the 
LF component. For example, earlier work by Inoue et al. (1990) suggested that LF power 
corresponds to cardiac sympathetic outflow, as individuals with complete tetraplegia 
failed to show any sign of it50. Contradicting work by Koh et al. (1994) demonstrated that 
LF power reflects cardiac vagal outflow, as atropine administration abolished LF power 
in individuals with SCI51. Guzzetti and colleagues (1994) showed that half of their cohort 
with complete tetraplegia exhibited a detectable LF component, suggesting that in some 
individuals, LF power corresponds to sympathetic spinal rhythmicity52. Moreover, Inoue 
et al. (1995) reported that the physiological correlates of LF power in individuals with 
tetraplegia may be different from that in able-bodied individuals, and that LF power in 
individuals with SCI is simply a reflection of reflex sympathetic outflow caused by 
stimuli from the periphery (bladder or bowel distension or spasms from the limbs)53. In 
conclusion, these conflicting results certainly lack a consensus on the physiological basis 
of LF power in individuals with SCI and therefore, this variable should be employed and 
interpreted with caution. High frequency power on the other hand has been shown to 
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reflect cardiac parasympathetic activity in individuals with SCI. In a recent study, Cotie 
et al. (2010) demonstrated a 99% ablation of HF power in individuals with SCI following 
atropine administration35.  
Although HF power reflects cardiac vagal outflow, reports have shown that it is 
reduced in individuals with SCI, suggesting attenuation of cardiac parasympathetic 
activity. This has been attributed to the body’s attempt to maintain cardiac sympathovagal 
modulation54,55. However, other investigators speculate that the reduction in HF power 
may be due to altered cholinergic receptor response to acetylcholine, as individuals with 
SCI demonstrate a blunted HR response to vagal withdrawal56. The same group also 
showed that compared to able-bodied individuals, those with SCI demonstrate less of an 
increase in HF power and a paradoxical increase in HR in response to the cold face test57. 
These observations suggest that a possible alteration in sino-atrial nodal response to vagal 
activity could be accountable for the reduced HF power reported following SCI. 
However, another possible explanation for the reduced HF power following SCI is the 
profound physical inactivity associated with this population. This is evidenced by Ditor et 
al. (2005b) who reported an increase in HF following an exercise program in individuals 
with SCI58. In addition, other studies have shown that physically fit SCI individuals have 
better HF dynamics compared to their sedentary counterparts, as shown by higher resting 
HF59 and faster post-exercise vagal recovery60.  
QT Variability Index in Spinal Cord Injury 
 
 Because the QTVI is a relatively novel index of cardiac autonomic modulation, 
there is a paucity of literature on this method in individuals with SCI. In the first study to 
investigate the QTVI in individuals with SCI, La Fountaine et al. (2010) compared 
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resting QTVI values between able-bodied controls and individuals with tetraplegia (C3-
C8; gross cardiac sympathetic dysfunction), high paraplegia (T1-T6; variable cardiac 
sympathetic dysfunction) and low paraplegia (T7-L5; cardiac sympathetic function 
intact)61. Results showed that all SCI groups had significantly elevated QTVI values 
compared to the able-bodied group (tetraplegia: -0.68±0.17; high paraplegia: -
0.63±1.32; low paraplegia: -0.65±0.99; able-bodied: -1.34±1.03; p=0.01) while there 
were no differences between any of the SCI groups. In addition, QTVI was negatively 
correlated with HF power in all SCI groups, which is in agreement with the previously 
mentioned observations from Piccirillo et al. (2009) suggesting that QTVI is elevated 
when vagal outflow is reduced5. Further, Ravensbergen et al. (2012) compared QTVI 
values between able-bodied controls and individuals with SCI who were further 
subdivided into groups based on 1) region of injury (cervical or thoracic), 2) level of 
injury (below or above/at T5), 3) autonomic completeness (complete or incomplete), and 
4) motor and sensory completeness (complete or incomplete)62. Similar to La Fountaine 
et al. (2010), the QTVI was significantly higher in all SCI individuals compared to the 
able-bodied group (-1.03 ± 0.100 vs. -1.31 ± 0.078; p= 0.019). Further analysis showed 
that QTVI values were related to the level of injury and autonomic completeness, as those 
with lesions above T5 and those with autonomically complete injuries had significantly 
higher QTVI compared to able-bodied controls62. 
 
Left Ventricular Functional Anatomy 
 
 The left ventricle (LV) is the thickest wall in the heart. It is located posteriorly 
and laterally to the right atrium and forms the apex of the heart. Its extra thick walls allow 
for the development of high enough pressures during contraction to eject blood 
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throughout the whole body. The LV is composed of three superimposed but 
interconnected layers, the epicardium, mid myocardium and endocardium. The different 
layers of the LV are arranged in a spiral/helical manner, resulting in counter directional 
twisting, providing an efficient distribution of regional stresses and strain63. When 
examining the LV transmurally, the muscle fibre direction is predominantly longitudinal 
in the endocardial layer, transitioning into a circumferential direction in the mid 
myocardium and then going back to being longitudinal in the epicardial surface64. In 
addition, the epicardium is oriented in a left helical plane (See Figure 8a) whereas the 
endocardial fibers are oriented in a right helical direction (See Figure 8b). The different 
muscle fibre orientation throughout the LV wall has functional implications that optimize 
contraction and relaxation.  
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Figure 8a: Cardiac Epicardial Layer 
                                                  
Figure depicts a left helical muscle fibre orientation. Figure from Sengupta et al. (2007)64.  
Figure 8b: Cardiac Endocardial Layer 
                                                  
Figure depicts right helical muscle fibre orientation. Figure from Sengupta et al. (2007)64. 
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Initially, the rapid spread of electrical activity during depolarization spreads in an 
apico-basal direction within the subendocardium, which initiates the contraction process. 
Following the spread of action potentials, the subendocardium shortens in a right-handed 
helical orientation, which results in a rapid build-up of intraventricular pressure, 
coinciding with the isovolumetric contraction period. This subendocardial shortening 
causes a simultaneous subepicardial fibre stretch which allows the muscle to optimize the 
length-tension relationship required for the subsequent contraction. During ejection, both 
the subendocardial and subepicardial layers contract in opposing spiral directions. 
Contraction force in the LV apex exceeds the contraction force in the base, causing the 
contractile to move in an apico-basal direction thus milking blood out of the LV when the 
intraventricular pressure exceeds that of the aorta64.  
Left Ventricular Diastolic Function 
  
Left ventricular diastole involves 3 stages: isovolumetric relaxation, early diastole 
and late diastole. Isovolumetric relaxation begins before aortic valve closure at the end of 
systole, which involves subendocardial untwisting in an apico-basal direction. The 
isovolumetric relaxation period makes up 40% of LV diastole and is the most critical 
period for normal LV relaxation to occur because it results in a rapid reduction in 
intraventricular pressure. Such a rapid reduction in intraventricular pressure creates a 
pressure gradient between the LV and left atrium which facilitates early passive LV 
filling when atrial pressure exceeds that of the LV. Early diastole is marked by mitral 
valve opening and rapid passive filling of the LV due to the pressure gradient formed 
during the isovolumetric period. In addition, the LV apex rapidly untwists during early 
diastole, creating a suction force which further augments the rapid movement of blood 
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from the left atria into the LV. At the end of early diastole, LV pressure exceeds that of 
the left atria due to the increased ventricular volume, which marks the end of early 
diastole. However, there remains a small amount of blood in the left atria, therefore, the 
left atria will contract and empty the remaining blood in it into the LV, marking late 
diastole. In contrast to early diastole, late diastole is an active process (atrial contraction) 
and the velocity of LV filling is much slower.  
Echocardiographic Assessment of Diastolic Function 
 
 Echocardiography employs ultrasound technology to assess LV diastolic function. 
This can be done via pulsed-wave Doppler or tissue Doppler (TD) techniques. Pulsed-
wave Doppler assesses the velocity of blood moving through the mitral valves during 
early and late diastole, whereas TD assesses the velocity of myocardial tissue during 
early and late diastole. From the pulsed-wave Doppler technique, early (E) and late (A) 
tranmsitral flow velocities can be measured as well as their ratio (E:A). Under normal 
conditions, most of the blood will fill the LV during early passive diastole, therefore, the 
E velocity is typically greater than A velocity resulting in an E:A ratio greater than 1. The 
deceleration time (DT) of early ventricular filling can also be assessed from the E 
transmitral wave. In addition, the isovolumetric relaxation time (IVRT) can be assessed 
as the time interval between aortic valve closure and the onset of ventricular filling (See 
Figure 9). As mentioned above, the TD technique examines myocardial tissue velocity 
during diastole. Peak early (Em) and late (Am) myocardial diastolic velocities can be 
assessed from the basal and septal annular segments of the LV (See Figure 10).  
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Figure 9: Pulse-Wave Doppler Measurement of Diastole 
 
 
 
 
 
 
 
E: early transmitral flow velocity; A: late transmitral flow velocity; IVRT: isovolumetric 
relaxation time; DT: deceleration time.  
 
 
 
Figure 10: Tissue Doppler Measures of Diastole 
 
 
 
 
 
 
 
 
 
Em: peak early myocardial diastolic velocity; Am: peak late myocardial diastolic 
velocity.  
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Cardiac Parasympathetic Activity and Diastolic Function 
 
 The effects of cardiac parasympathetic activity on LV diastolic function are not 
very well understood. In particular, there is a paucity in the literature on the interaction 
between cardiac autonomics and echocardiographic parameters of diastole in healthy 
populations. There is however evidence suggesting that vagal outflow may impact 
cardiac relaxation by altering atrial contractility. Generally, studies have shown that an 
increase in cardiac vagal outflow may reduce atrial contractility, whereas an attenuation 
in cardiac vagal outflow may increase atrial contractility. A study in dogs by Williams et 
al. (1965)65 demonsrated a 19% reduction in atrial contractile force following vagal nerve 
stimulation, which was also later shown by Steusse et al. (1979)66. Likewise, another dog 
study showed that direct vagal nerve stimulation resulted in an increase in early diastolic 
filling by 24%, which was accounted for by an increase in left atrial pressure67. In human 
studies, Finkelhor et al., (1995) showed that the age induced increase in transmitral A 
velocity was closely related to the reduction in HRV (r=-0.54; p=0.002)68. Similarly, 
cholinergic blockade via atropine was shown to decrease E velocity by 23%, increase A 
velocity by 103%, and consequently decrease the E:A ratio by 60% 69. This is accordance 
with results from Stratton et al. (2003) who showed a reduction in early diastolic filling 
following parasympathetic withdrawal in humans70.  A more recent study showed that 
healthy participants who had an E:A ratio <1 demonstrated significantly lower HF power 
compared to those with an E:A ratio >111. This suggests that those individuals with 
reduced HRV may demonstrate a reduction in the E:A ratio due to elevated atrial 
contraction. Accordingly, these studies suggest that in healthy normal conditions, 
elevated cardiac vagal outflow may increase atrial pressure thus increasing early diastolic 
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velocity. In contrast, a reduction in cardiac vagal outflow increases atrial contractility, 
thus making the LV rely more on late diastole.   
Preload and Diastolic Function 
 
 Doppler indices of LV diastolic function are substantially governed by factors that 
affect LV and left atrial pressures. As mentioned before, normal early diastolic function is 
driven by a pressure gradient that results in rapid and passive blood flow from the atria to 
the ventricle. Therefore, early and late diastolic velocities are influenced by factors that 
simultaneously affect LV and atrial pressures. Thus, interventions that increase left atrial 
pressure would subsequently increase early diastolic velocity, whereas a reduction in left 
atrial pressure would attenuate early diastolic velocity10. Preload is partly defined by the 
pressure in the LV at the end of diastole. An increase in preload suggests an increase in 
cardiac filling, which can be due to increased blood volume, increased atrial contractility 
and/or increased ventricular elasticity71. The most direct evidence demonstrating the 
effect of preload on diastolic function can be derived from models of hemodialysis. Assa 
et al. (2013) reported a significant reduction in transmitral E and TD Em velocities after 
reduced preload during a dialysis session72.  Additional Doppler measures of diastole 
were also impaired during hemodialysis, such as prolongation of DT and IVRT72. These 
results are in agreement with past studies showing diastolic impairment in response to 
reduced preload73,74. A dose dependent reduction in transmitral E velocity has also been 
demonstrated in response to gradual increases in lower body negative pressures, whereas 
a dose dependent increase in transmitral E velocity has been shown in response to gradual 
increases in saline infusion75. The same investigators also demonstrated that TD Em 
velocities increase after rapid saline infusion and decrease after caval occlusion75. 
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Furthermore, Mak et al. (2013) demonstrated a significant increase in transmitral E and 
TD Em velocities in healthy individuals after increasing preload via rapid saline infusion 
and a high salt diet76.    
Physical Activity and Diastolic Function 
 
 Most of the knowledge obtained on cardiac adaptations to physical inactivity is 
derived from studies of bed rest and spaceflight. Bed rest and spaceflight models are used 
as analogues to severe physical inactivity in order to understand the cardio-physiological 
adaptations to sedentary life. Interestingly, most studies show that following a given 
period of physical inactivity, LV systolic function is unaltered whereas diastolic 
impairments start to develop. For example, Atkov et al. (1987) indicated that the 
reduction in stroke volume in astronauts following 8 months of spaceflight was due to 
hemodynamic alterations, as cardiac contractility was unaltered77. Similar observations of 
preserved systolic function have also been reported from bed rest studies lasting more 
than a year78. Moreover, Levine et al. (1997) showed that 2 weeks of bed rest resulted in 
a 17% reduction in plasma volume and concomitant impairments in ventricular filling79. 
Furthermore, Perhonen et al. (2001) reported a 14% reduction in LV end diastolic volume 
at 2 weeks of bed rest, and an additional 8% reduction by 12 weeks, resulting in reduced 
diastolic filling80. This was attributed to the well-documented reduction in plasma volume 
following a period of physical inactivity81. Moreover, Carrick-Ranson et al. (2013) 
examined LV diastolic function following a 5-week period of bed rest in an exercising 
and non-exercising group. Results showed that only the non-exercising group exhibited a 
significant reduction in E (79±17 to 67±14 cm s−1: p= =0.001) and Em (14±3 to 13±3 cm 
s−1; p=0.02), as well as an increase in IVRT (93±24 to 110±24 msec; p=0.02). 
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Interestingly, all of these parameters returned to baseline values following saline infusion, 
suggesting that reduced diastolic function following a period of physical inactivity may 
be influenced by changes in loading conditions rather than intrinsic ventricular 
properties82.   
Spinal cord injury and diastolic function 
  
 Hemodynamic variables of LV systolic function, such as ejection fraction and 
stroke volume, are typically unaltered in individuals with SCI7,8,56,83 suggesting preserved 
systolic function in this population. Findings on LV diastolic function in individuals with 
SCI remain equivocal however, as previous reports suggest preserved diastole while more 
recent studies demonstrate impaired diastolic function. For example, De Groot et al. 
(2006) reported similar diastolic function between individuals with complete tetraplegia 
and able-bodied individuals via pulse-wave Doppler, TD and pulmonary parameters of 
diastole8. Similar results of preserved diastolic function have also been reported in 
individuals with paraplegia84, older sedentary individuals with tetraplegia9, untrained 
individuals with SCI85 and rugby athletes with SCI86. All of these studies also report an 
“adaptive” reduction in cardiac dimensions in response to the reduced venous return that 
is accompanied by SCI. It has been hypothesized that such a reduction in cardiac 
dimensions maintains the mass:volume ratio and preserves cardiac wall stress, which may 
explain the preserved diastolic performance in those with SCI8,86. 
However, more recent studies on diastolic function in SCI contradict the 
aforementioned findings. For example, Driussi et al. (2014) showed that individuals with 
complete paraplegia had significantly lower transmitral  E velocity, E:A ratio as well as 
TD Em compared to able-bodied controls6. In addition, results from Matos-Souza et al. 
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(2010) showed that individuals with SCI had a lower Em compared to controls, as well as 
a higher LV filling pressure7. In addition, the participants who had an E:Em ratio greater 
than eight exhibited elevated relative wall thickness and lower peak myocardial systolic 
velocity, both of which are patterns associated with diastolic heart failure10. In order to 
determine the effects of physical activity on diastolic function in SCI, Rossi et al. (2014) 
compared echocardiographic diastolic parameters between physically active SCI (SCI-A), 
sedentary SCI (SCI-S) and able-bodied controls. Results showed that SCI-S presented 
higher E:Em ratio compared to SCI-A and controls (SCI-S: 8.0±0.5; SCI-A: 6.4±0.3; AB: 
5.9±0.3; p<0.05) and lower Em:Am ratio (SCI-S: 1.18±0.09; SCI-A: 1.57±0.12; controls: 
1.63±0.08; p<0.05)83. When comparing SCI groups according to level of injury, 
sedentary tetraplegics had significantly lower Em compared to active tetraplegics 
(8.6±0.5cm/s vs. 10.9±0.6cm/s; p<0.05). These results are in agreement with findings by 
Schreiber et al. (2014) who reported significantly lower E:A ratio in  SCI-S compared to 
SCI-A (1.43±0.09 vs 1.71±0.08; p=0.02) as well as lower Em (9.3±0.6cm/s vs 
11.0±0.6cm/s; p=0.04) and higher E:Em ratio (7.7±0.5 vs 6.4±0.3; p=0.02)87.  
 It is important to note that Doppler indices of LV diastolic function are highly 
influenced by preload88. After SCI, there is a hemodynamic shift towards reduced preload 
as a result of reduced venous return. Such a reduction in venous return can be explained 
by the lower total blood volume seen in individuals with SCI89, reduced vascular 
sympathetic tone below the injury90 and ablation of the muscle pump effect. One or a 
combination of all these factors can collectively reduce the amount of blood that returns 
to the heart, thus decreasing cardiac filling. Accordingly, it is possible that the reported 
alterations in LV diastolic function after SCI are a result of reduced preload rather than 
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intrinsic architectural alterations in the LV. In addition, individuals with SCI may 
demonstrate impaired cardiac vagal outflow as a result of the profound physical inactivity 
which typically occurs after paralysis. As reported above, alterations in cardiac vagal 
activity can also have an influence on LV diastolic function. Therefore, it is possible that 
the reported alterations in LV diastole in those with SCI could be related to autonomic 
impairments. Accordingly, further studies are warranted in order to elucidate the 
mechanisms behind the reported diastolic impairments in individuals with SCI.  
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Chapter 3 – Purpose & Hypotheses 
 
Manuscript 1: The influence of cardiac autonomic activity on the QT-variability 
index in able-bodied and incomplete spinal cord injured individuals.  
The purpose of this study was to use pharmacological blockade of the sympathetic 
and parasympathetic regulation of the heart to determine the relationship between the 
QTVI and cardiac autonomic regulation in individuals with autonomically incomplete 
SCI and able-bodied controls. We hypothesized that 1) the QTVI would increase with the 
transition from supine rest to cardiovascular stress, in both individuals with autonomic 
incomplete SCI and the able-bodied. Further, during cardiovascular stress, the QTVI will 
be significantly reduced with β-blockade in both groups. These findings would provide 
evidence that the QTVI is an index of cardiac sympathetic regulation during autonomic 
arousal. 2) we also hypothesized that during resting conditions, the QTVI will increase 
after parasympathetic blockade via atropine in both the autonomic incomplete SCI and 
able-bodied groups.   
Manuscript 2: Reproducibility of the QT-variability index in individuals with spinal 
cord injury.  
 
The purpose of this study was to examine the day-to-day reproducibility of the 
QTVI in individuals with SCI. This was done via an intraclass correlation coefficiency 
test. We hypothesized that the QTVI would show good intraclacc correlation coefficiency 
values and high reproducibility as a measure of cardiac autonomic function.  
Manuscript 3: Cardiac autonomic and ventricular diastolic interaction in individuals 
with spinal cord injury.  
 
This is an exploratory study aiming to examine 1) the relationship between resting 
cardiac parasympathetic activity and LV diastolic function in able-bodied and SCI 
individuals at rest and 2) LV diastolic changes in response to cardiac parasympathetic 
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stimulation via the cold face test (CFT) in able-bodied and SCI individuals. We 
hypothesized that 1) both able-bodied and SCI individuals would show positive 
correlations between cardiac parasympathetic activity and early diastolic filling velocity. 
2) We also hypothesized that an increase in cardiac vagal outflow via the CFT would 
result in increased diastolic filling velocity in both groups. 
Manuscript 4: The effect of blood volume and volume loading on left ventricular 
diastolic function in individuals with spinal cord injury.     
 
The purpose of this study was to determine if individuals with SCI demonstrate 
diastolic impairments at rest and/or during a volume stress induced by rapid saline 
infusion. We also aimed to determine if reductions in blood volume following SCI 
contribute to the putative diastolic impairments in this population. We hypothesized that 
individuals with SCI would demonstrate reduced diastolic function as a result of being 
hypovolemic. We also hypothesized that individuals with SCI would show normal 
diastolic responses to the rapid saline infusion.   
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Abstract: 
Objectives: To investigate, via autonomic blockade, if the QT-variability index (QTVI) 
is a measure of cardiac autonomic regulation in able-bodied (AB) and incomplete spinal 
cord injured (SCI) individuals.  
Methods: Four SCI (41.6±13.4 years; C4-C7, AIS B-D, 13.4±13.4 years post injury) and 
4 AB (33.0±7.8 years) individuals were tested. QTVI was determined from 
electrocardiographic readings obtained during supine rest and cardiovascular (CV) stress, 
with and without autonomic blockade. CV stress was induced by 40° head-up tilt, the 
hand submerged in 10°C water and the jaw clenched. Autonomic blockade was achieved 
with metoprolol (β-blockade) and atropine (cholinergic blockade).  
Results: There was no group x condition interaction for QTVI, although there was a 
significant main effect for condition. After collapsing across groups, QTVI increased 
with CV stress (p=0.01) and decreased with subsequent β-blockade (p=0.04), suggesting 
that during CV stress, QTVI is reflective of cardiac sympathetic activity. During supine 
rest, β-blockade did not change QTVI (p=0.24), however, cholinergic blockade increased 
QTVI (p<0.001), suggesting that during rest, QTVI is inversely related to cardiac 
parasympathetic regulation. 
Conclusion: During times of CV stress, QTVI reflects cardiac sympathetic activity, 
while during resting conditions, QTVI is inversely related to cardiac parasympathetic 
activity. These relationships persist after autonomic incomplete SCI.   
 
Key Words: QTVI, Autonomic blockade, Spinal cord injury  
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Introduction: 
 
The QT interval on the electrocardiogram (ECG) corresponds to the duration of 
global ventricular repolarization. When analyzed on a beat-to-beat basis, the duration of a 
series of QT intervals shows a certain amount of variability, which can be quantified by 
the QT variability index (QTVI)1. From a clinical perspective, a rise in the QTVI is 
indicative of increased beat-to-beat repolarization variability, which is predictive of 
future arrhythmias and sudden cardiac death2. From a physiological perspective, previous 
literature has shown that QTVI may be influenced by the autonomic nervous system; 
specifically, sympathetic outflow to the heart in conditions of cardiac-related morbidity. 
This notion of sympathetic involvement is supported by clinical studies that examined 
disorders associated with elevated sympathetic tone, and experimental studies that 
induced sympathetic activation via head-up tilt or administration of sympathomimetic 
agents. Regarding the clinical studies, an elevated QTVI has been reported in individuals 
with cardiac conditions such as dilated cardiomyopathy1, hypertension3,4 , congestive 
heart failure5 and chronic heart failure6, all of which are associated with increased 
efferent sympathetic tone acting on the end-organ. An elevated QTVI has also been 
reported in non-cardiac conditions associated with elevated sympathetic activity, such as 
obstructive sleep apnea7, panic disorder and depression8. Regarding the experimental 
studies, a head-up tilt test and the intravenous infusion of the β-adrenoceptor agonist 
isoprotenerol have been shown to increase QTVI in healthy individuals further 
demonstrating the sensitivity of QTVI to the physiological state9. However, other studies 
in animals10 and humans11 have provided evidence that the QTVI may be influenced by 
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vagal regulation as well. Piccirillo et al. (2009) demonstrated in animal models, that 
baseline resting QTVI was inversely correlated with vagal nerve activity10.  
Spinal cord injury (SCI) is associated with severe cardiac autonomic dysfunctions, 
mainly due to loss of supraspinal control over sympathetic regulation to the heart and 
vasculature12. Consequences of this impaired sympathetic regulation include bradycardia, 
due to unopposed vagal outflow to the sinoatrial node, and hypotension due to a loss of 
sympathetic outflow to the sublesional vessels13. Further, and unique to SCI, individuals 
with high paraplegia or tetraplegia may experience autonomic dysreflexia; a condition 
characterized by episodes of uncontrolled sympathetic reflexes that lead to elevations in 
blood pressure, which in severe cases, have caused cerebral hemorrhages or even death14. 
Despite the noted impairments in cardiac autonomic regulation after SCI, a consensus 
method of determining the amount of preserved cardiac autonomic function has yet to be 
developed for this population. Accordingly, the QTVI may potentially serve as a non-
invasive method for measuring cardiac autonomic function in individuals with SCI, and 
previous work in this area has shown some promise. For example, La Fountaine et al. 
(2011) reported that individuals with tetraplegia, who have impaired cardiac autonomic 
regulation, exhibit higher QTVI values compared to healthy controls11. In addition, 
Ravensbergen et al. (2012) demonstrated higher QTVI values in those with 
autonomically complete SCI compared to those with autonomically incomplete SCI15. 
Therefore, it is clear that the QTVI is influenced by cardiac autonomic alterations after 
SCI, and it may have some diagnostic value. If the QTVI is a valid index of cardiac 
autonomic control, it may be of great use to the SCI population as a means to gauge 
deficits in cardiac autonomic regulation, and potential improvements with time, or 
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various forms of intervention (exercise, pharmacological, or neurological or otherwise). 
Accordingly, the purpose of this study was to use pharmacological blockade of the 
sympathetic and parasympathetic regulation of the heart to determine the relationship 
between the QTVI and cardiac autonomic regulation in individuals with autonomically 
incomplete SCI and able-bodied (AB) controls.  
Hypotheses: 
 
We hypothesized that the QTVI is a useful surrogate of autonomic control in 
individuals with autonomic incomplete SCI, as it will reflect cardiac sympathetic 
regulation during autonomic arousal, and reflect cardiac parasympathetic regulation at 
rest. Thus, with respect to the current protocol, we hypothesized that: 
1) the QTVI will increase with the transition from supine rest to cardiovascular 
stress, in both individuals with autonomic incomplete SCI and the able-bodied. 
Further, during cardiovascular stress, the QTVI will be significantly reduced with 
β-blockade in both groups. These findings would provide evidence that the QTVI 
is an index of cardiac sympathetic regulation during autonomic arousal.  
2) during resting conditions, the QTVI will increase with decreases in cardiac 
parasympathetic regulation, in both individuals with autonomic incomplete SCI 
and the able-bodied. In other words, we hypothesized that during supine rest, the 
QTVI will increase with a decrease in parasympathetic regulation induced by 
muscarinic cholinergic blockade. These findings would provide evidence that the 
QTVI is inversely related to cardiac parasympathetic regulation during times of 
rest.      
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Methods: 
Participants: 
 Participants in the current study included 4 individuals with incomplete SCI (C4-
C7, AIS B-D, 13.4±13.4 years post-injury) and 4 able-bodied individuals, matched for 
age, weight and height. No participant had any history of cardiovascular disease (CVD), 
as the QTVI is highly influenced by CVD. Participants were also required to be free of 
asthma and/or glaucoma, as these conditions are contraindications for metoprolol tartrate 
and atropine sulfate, respectively, which were used for the pharmacological blockade in 
this study. Likewise, participants were screened to exclude those who were taking any 
other medication that would contraindicate atropine sulfate and metoprolol tartrate 
administration. Screening prior to admission into this study, for both incomplete SCI and 
AB participants, was conducted by a physician and all participants provided informed 
consent prior to enrolling into this study. All participants gave their informed consent to 
participate in the study, and all procedures were approved by the Brock University 
Research Ethics Board and the Hotel Dieu Shaver Research Ethics Board.  
Study Design: 
The current investigation was a further analysis of data collected previously for 
the current cross-sectional investigation measured QTVI before and after 
pharmacological autonomic blockade in the supine and cardiovascular stress positions. 
Cardiovascular stress was induced by 40° head-up tilt, a submaximal isometric jaw 
contraction, and the right hand submerged in 10°C water. The water bath was maintained 
at 10°C throughout the entire protocol via a Polyscience 5000 Series chiller (Model 
5205). These three stimuli were used in concert to ensure that the sympathetic nervous 
system was maximally activated. Previous research has shown that only when these three 
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manoeuvres were used together did sympathovagal balance increase significantly 
compared to supine baseline values in individuals with tetraplegia16. Further, Houtman et 
al., (2000), determined that head-up tilt alone was not sufficient to increase sympathetic 
activity in individuals with tetraplegia17. Autonomic blockade was performed by a 
Physician, and included the intravenous administration of metoprolol tartrate (Sabex Inc.) 
at a maximum dosage of 15mg (3x5mg), and atropine sulfate (Alveda Pharmaceuticals 
Inc.) at a dosage of 0.02 mg/kg. Atropine sulfate is a muscarinic cholinergic antagonist 
which blocks parasympathetic transmission to the sinoatrial node, while metoprolol 
tartrate is a β1-adrenergic antagonist that blocks sympathetic transmission to the sinoatrial 
node. For the sake of safety, metoprolol tartrate administration was terminated once the 
heart rate (HR) reached a nadir, or if it was anticipated that the next 5mg dose would 
decrease the HR to less than 40 beats/min. 
Study Protocol: 
All participants were tested on two separate occasions. Visit 1 included a meeting 
with the Physician for medical clearance to participate in the study. This included 
screening for any history of cardiovascular disease, asthma, glaucoma, or smoking, as 
well as recording the cause of injury, and the level and severity of injury as determined 
by the American Spinal Injury Association Impairment Score (AIS). Participants were 
also familiarized with the study protocol and the laboratory setting, and informed consent 
was obtained.  
During visit 2, participants reported to the laboratory for testing (Brock Heart 
Institute, St. Catharines, Canada). After voiding their bladders (to reduce the risk of 
autonomic dysreflexia during testing), participants were transferred to a tilt table, such 
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that no physical exertion was required by the participant. While supine, a catheter was 
inserted into the antecubital vein for drug administration, and the skin was prepared for 
electrode placement.  Two separate electrocardiogram (ECG) recordings were taken 
during the testing protocol. For the sake of safety, participants had a 12-lead ECG to 
monitor for cardiac rhythm disturbances that could have occurred during the testing 
protocol, and a single-lead ECG to collect the continuous HR data for QTVI analysis 
using Power Lab and the software program Lab Chart 7 (ADInstruments). Both ECG 
recordings were collected at a sampling frequency of 1000Hz. To ensure a true resting 
baseline, all participants were required to lie supine on the tilt table in a dark quiet room 
for 10 minutes prior to data collection. Following this rest period, 10 minutes of baseline 
ECG was recorded in the supine position followed by another 10 minutes of ECG 
recording with the participant in the cardiovascular stress position. Following the 
cardiovascular stress position, participants were returned to the supine position. Once 
cardiovascular variables (blood pressure and HR) had returned to baseline, a maximum 
dose of 15mg of metoprolol tartrate was administered intravenously in three 5mg doses. 
Each 5mg dose was given over a 5 minute period with 5 minutes of rest between doses. 
As mentioned, metoprolol tartrate administration was terminated once the HR reached a 
nadir or if it was anticipated that another dose would decrease HR to less than 40 
beats/min. Following this administration, ECG was again recorded for 10 minutes in the 
supine position and then for 10 minutes in the cardiovascular stress position. Participants 
were then returned to the supine position again and given intravenous administration of 
atropine sulfate at a dosage of 0.02 mg/kg16. Again, ECG was recorded for 10 minutes in 
the supine position. This entire protocol is represented in Figure 1. Participants refrained 
53 
 
 
 
from smoking, alcohol or caffeine consumption within twelve hours of the second 
laboratory visit. Likewise, medications were not interrupted during the study however, 
only baclofen and ditropan may have affected our measures. Although all of the 
incomplete SCI participants were taking these medications, the cardiovascular side 
effects are rare and transient18. 
 
Figure 1: Study Protocol 
 
CV: cardiovascular stress, which involved 40° head-up tilt, a submaximal isometric jaw 
contraction and the right hand submerged in 10°C water. 
 
QT Interval and Variability Analysis: 
 Electrocardiographic (ECG) signals for the current study were a further analysis 
of previously collected data by our group, for the assessment of heart rate variability 
(HRV) under different conditions19. None of the participants showed any arrhythmia and 
less that 1% of the beats were ectopic. For the purpose of the current study, ECG analysis 
was performed on 256 stable, artifact-free beats from the 10 minute continuous ECG 
recording in each experimental condition. A 50Hz low-pass filter was implemented to 
eliminate high frequency (HF) noise in order to obtain the clearest possible ECG signals 
for the analysis. The QT interval was determined as the time duration between the onset 
of the Q-wave, and the intersection point of the isoelectric line with the T-end. The T-end 
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was determined by creating a tangent line, fitted by least squares, to the descending slope 
of the T-wave over a data range 70%-30% of T-peak. Prior to further analysis, each beat 
was visually examined in order to ensure that the software determined and marked the 
QT intervals appropriately. The QTVI was calculated using the following formula 
developed by Berger et al., (1997):  
QTVI = Log10 [(QTv/QTm
2) / (RRv/RRm2)]  
where, QTv is the QT interval variance, QTm2 is the mean QT interval squared, RRv is 
the RR interval variance and RRm2 is the mean RR interval squared1 .  
The QT interval corrected for heart rate (QTc) was also calculated by using the 
subject specific method developed my Malik et al., since traditional formulas of 
calculating QTc can produce misleading results when used in conjunction with HR 
altering drugs20. 
Statistical Analysis: 
 Two-way (group x condition) repeated measure of analyses of variance 
(ANOVA) were used to determine differences in QTVI, QTv, and RRv. Bonferroni’s 
post-hoc test was used to compare means if significant interactions or main effects were 
found. One-way repeated measures ANOVA were used to determine differences in HR, 
QT, QTc and RRv between conditions and the Bonferroni’s post-hoc test was used to 
compare means when significant main effects were found. A student’s t test was used to 
determine differences in QTVI between groups during supine rest and to determine 
differences in mean arterial pressure (MAP) between conditions and anthropometric 
measurements between groups. All statistical analyses were performed using SPSS 
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software, all values were reported as means ± standard deviation, and the level of 
statistical significance was set at p < 0.05.   
Results:  
 
Participant characteristics are shown in Table 1. There were no significant 
differences between groups for age, weight or height. However, the SCI group consisted 
of 4 males where AB group consisted of 3 males and 1 female. In addition, the SCI group 
did not show significant changes in MAP when moved from the supine condition to the 
CV stress condition (87.0 ± 8.7 mmHg to 81.7 ± 8.5 mmHg; p=0.11), and its HR 
responses to autonomic stimuli were similar to that exhibited by the AB group (Table 3), 
suggesting that this cohort of SCI individuals is autonomically incomplete.  
 
Table 1: Participant characteristics 
Characteristics Able-Bodied SCI p value 
Age 33.0 ± 7.8 41.6 ± 13.4 0.37 
Sex 3 Male, 1 Female 4 Male N/A 
Weight 
(Kg) 
83.0 ± 18.9 70.8 ± 15.2 0.27 
Height 
(cm) 
176.3 ± 9.8 174.7 ± 10.8 0.50 
Years Post Injury NA 13.4 ± 13.4  
Level of Injury NA 1 C4; 3 C5  
AIS Score NA 2 B; 2 C  
AIS: AISA Impairment Score, where ASIA denotes American Spinal Injury Association 
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QTVI: 
 There was no significant difference between groups for QTVI during supine 
resting conditions (AB: -1.6 ± 0.4; SCI: -1.0 ± 0.6; p= 0.20).  
Regulation of cardiac sympathetic outflow and QTVI: 
 The results of the 2-way ANOVA revealed no significant group x condition 
interaction for QTVI (p=0.97) nor a significant main effect for group (p=0.14). However, 
there was a significant main effect for condition (p=0.003). Post-hoc analysis of this main 
effect showed a significant increase in QTVI when participants (all participants, 
collapsed across group) were moved from the supine to the CV stress position (p=0.01).  
Post hoc analysis also showed that when participants (all participants, collapsed across 
group) were in the CV stress position (autonomically aroused) the QTVI was 
significantly reduced by the administration of metoprolol (p=0.04) (Figure 2). QT-
variability index data for each participant during sympathetic regulation is provided in 
Table 2. Changes in the QTVI can be caused by either changes in the QTv or the RRv. As 
such, we analyzed these variables as well to determine which was responsible for the 
observed changes in QTVI caused by CV stress and β-blockade. Two-way ANOVA 
showed that there was no significant group x condition interaction for QTv (p=0.62), nor 
a significant main effect for group (p=0.36), however, there was a significant main effect 
for condition (p=0.02). Post hoc analysis showed a significant increase in QTv when 
participants were moved from the supine to the CV stress position (p=0.02), but unlike 
QTVI, QTv did not change after metoprolol administration (p=0.25) (Table 3). Two-way 
ANOVA also showed that there was no significant group x condition interaction for RRv 
(p=0.21), and no main effect for either group (p=0.13) or condition (0.47) (Table 3). 
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These results show that QTv behaves in a similar manner to QTVI in response to 
autonomic stimulation. This suggests that sympathetically-induced elevations in QTVI 
may be due to changes in QTv and not RRv.  
 
Figure 2: QTVI and Cardiac Sympathetic Regulation 
 
There was no significant group x condition interaction, and therefore the data is presented 
for each group (dotted lines) and collapsed across groups (solid line). Significant changes 
pertain to the collapsed data. Values are means ± standard deviation.  
* denotes a significant increase (p=0.01) in QTVI compared to the supine condition 
(collapsed across groups)  
† denotes a significant decrease (p=0.04) in QTVI compared to the CV stress condition 
(collapsed across groups).  
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Table 2. Cardiac Sympathetic Regulation and Individual QTVI Values 
 
Group Participant Supine CV Stress CV Stress + Met 
 
SCI 
 
1 -0.3 0.3 -0.01 
2 -1.1 -1.0 -1.3 
3 -1.8 -0.9 -0.9 
4 -0.9 -0.4 -0.9 
 
AB 
1 -1.1 -0.7 -1.0 
2 -1.9 -1.3 -1.9 
3 -1.8 -1.1 -0.9 
4 -1.5 -1.1 -1.5 
SCI: Spinal cord injury; AB: Able-bodied; CV: Cardiovascular; Met: Metoprolol 
 
 
 
Table 3: Cardiac Sympathetic Regulation and QTv, RRv and HR 
AB: Able-bodied; CV: Cardiovascular; SCI: Spinal cord injury; QTv: QT-interval 
variance; RRv: RR-interval variance; HR: Heart rate; *denotes significantly different 
from Supine (p<0.05) 
 
 
  
Group 
Condition 
Supine CV stress 
CV stress + 
Metoprolol 
QTv          
(ms) 
SCI 44.9 ± 61.9 73.0 ± 80.1 38.5 ± 38.4 
AB 8.4 ± 2.8 38.7 ± 17.1 19.9 ± 15.8 
Collapsed 26.7 ± 32.4 55.8 ± 48.6* 29.2 ± 27.1 
RRv           
(ms) 
SCI 2705.7 ± 2036.8 1326.5 ± 916.8 1355.4 ± 703.9 
AB 3233.7 ± 1770.0 3240.7 ± 1348.8 3881.4 ± 2276.4 
Collapsed 2969.7 ± 1903.5 2283.6 ± 1132.9 2618.4 ± 1490.2 
HR       
(beats/min) 
SCI 57.9 ± 6.5 67.9 ± 11.6 64.7 ± 12.3 
AB 51.5 ± 3.8 59.0 ± 6.3 51.2 ± 3.6 
Collapsed 54.7 ± 5.2 65.7 ± 9.9 58.0 ± 8.0 
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Regulation of cardiac vagal outflow and QTVI: 
  The results of the 2-way (group x condition) ANOVA showed no significant 
interaction for QTVI (p=0.89) nor a significant main effect for group (p=0.12). However, 
there was a significant main effect for condition (p<0.001). Post-hoc analysis of this main 
effect (for all participants, collapsed across group) showed that the administration of 
metoprolol during the supine position caused no significant changes in QTVI (p=0.24). 
However, the administration of atropine caused a significant increase in QTVI compared 
to the other two conditions; the supine condition (p<0.001) and the supine condition with 
metoprolol (p<0.001) (Figure 3). QT-variability index data for each participant during 
parasympathetic regulation is provided in Table 4.  Again, changes in the QTVI can be 
caused by either changes in the QTv or the RRv. As such, we analyzed these variables as 
well to determine which was responsible for the observed changes in QTVI caused by 
cholinergic blockade. The results of the 2-way ANOVA showed no group x condition 
interaction for QTv (p=0.62), nor a significant main effect for group (p=0.30) or 
condition (p=0.22) (Table 5). For RRv, the results of the 2-way ANOVA showed that 
there was no group x condition interaction (p=0.24) nor a significant main effect for 
group (p=0.34). There was, however, a significant main effect for condition (p<0.001) 
(Table 5). Post-hoc analysis of this main effect showed that when participants were in the 
supine position, the administration of metoprolol resulted in a trend towards an increase 
in RRv (p=0.09). Post-hoc analysis also showed that atropine administration caused a 
significant decrease in RRv compared to the other two conditions; the supine condition 
with no drug administration (p=0.02) and the supine condition with metoprolol (p=0.01) 
(Table 5). These results suggest that RRv responds to vagal regulation during resting 
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supine conditions, and suggest that changes in QTVI during resting supine conditions 
may be due to changes in RRv and not QTv.  
 
 
Figure 3: QTVI and Cardiac Parasympathetic Regulation 
 
There was no significant group x condition interaction, and therefore the data is presented 
for each group (dotted lines) and collapsed across groups (solid line). Significant changes 
pertain to the collapsed data. . Values are means ± standard deviation.  
 * denotes a significant increase (p<0.001) in QTVI compared to the supine condition 
(collapsed across groups) and the supine + metoprolol condition (collapsed across 
groups) .  
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Table 4: Cardiac Parasympathetic Regulation and Individual QTVI Values 
Group Participant Supine Supine + Met Supine + Met + Atrop 
 
SCI 
 
1 -0.3 -0.5 0.4 
2 -1.1 -1.4 0.8 
3 -1.8 -1.7 0.02 
4 -0.9 -1.2 0.2 
 
AB 
1 -1.1 -1.3 0.4 
2 -1.9 -2.5 -0.6 
3 -1.8 -2.3 -0.3 
4 -1.5 -1.3 -0.2 
AB: Able-bodied; Atrop: Atropine CV: Cardiovascular; Met: Metoprolol; SCI: Spinal 
cord injury 
 
 
 
Table 5: Cardiac Vagal Regulation and QTv, RRv and HR 
 
 
AB: Able-bodied; CV: Cardiovascular; SCI: Spinal cord injury  
*denotes significantly different from Supine (p<0.05) 
† denotes significantly different from Supine + Metoprolol (p<0.05) 
 
  
Group 
Condition 
Supine 
Supine + 
Metoprolol 
Supine + Metoprolol 
+ Atropine 
QTv          
(ms) 
SCI 44.9 ± 61.9 31.5 ± 28.9 47.2 ± 39.1 
AB 8.43 ± 2.7 9.4 ± 5.1 28.6 ± 35.5 
Collapsed 26.7 ± 32.4 20.5 ± 17.0 38.0 ± 37.3 
RRv           
(ms) 
SCI 2705.6 ± 2036.8 3658.9 ± 1485.3 121.2 ± 94.9 
AB 3233.7 ± 1770.0 6624.8 ± 4243.1 129.1 ± 25.5 
Collapsed 2969.7 ± 1903.5 5141.9 ± 2864.2 125.2 ± 60.2*† 
HR       
(beats
/min) 
SCI 57.9 ± 6.5 57.9 ± 6.4 83.0 ± 15.3 
AB 51.5 ± 3.8 44.8 ± 2.5 83.2 ± 29.0 
Collapsed 54.7 ± 5.2 51.4 ± 4.5 83.2 ± 22.2 
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Discussion: 
 
 The main findings of the current investigation were that in both AB participants 
and those with autonomically incomplete SCI, 1) QTVI significantly increased at times of 
elevated CV stress, 2) administration of the β-adrenoceptor antagonist, metoprolol, 
during CV stress significantly reduced QTVI and 3) in supine resting conditions, the 
administration of atropine significantly increased QTVI. These findings demonstrate that 
the QTVI is indeed influenced by cardiac autonomic activity, both sympathetic and 
parasympathetic, depending on the dominant system. The increase in QTVI during CV 
stress and its subsequent reduction after administration of metoprolol suggest that QTVI 
may reflect sympathetic activity at times of elevated CV stress. However, the rise in 
QTVI in response to atropine administration during supine resting conditions suggests 
that it may be inversely related to vagal activity during rest.  
 According to previous literature, QTVI is thought to be a reflection of 
sympathetic outflow to the heart. Yeragani et al. (2000b) demonstrated, in healthy adults, 
an increase in QTVI in response to isoprotenerol infusion and after head-up tilt, both of 
which are associated with increased sympathetic tone9. Also, administration of the β-
blocker propranolol resulted in the attenuation of QT variability during atrial pacing in 
individuals without structural heart disease21. In addition, individuals with chronic 
cardiovascular morbidity exhibit higher QTVI values compared to healthy controls3-7. 
Although chronic cardiac conditions are associated with autonomic imbalances, they are 
also characterized by end organ pathology that may contribute to the elevated 
repolarization lability. Pathological alterations to the myocardium result in beat-to-beat 
action potential duration variability, rendering the myocardium unstable and predisposing 
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it to arrhythmias22. Prolongation of the QT interval is also seen in cardiomyopathies, 
which predisposes the myocardium to early after depolarization and may increase 
transmural dispersion of repolarization, both of which increase the risk of 
arrhythmias23,24. Therefore, individuals with cardiomyopathies likely demonstrate an 
increase in QTVI due to a combination of myocardial damage and elevations in 
sympathetic tone.  
Spinal cord injury on the other hand, is not necessarily associated with myocardial 
damage. Accordingly, the previously reported elevations in QTVI in individuals with SCI 
compared to the able-bodied11,15 are likely due to autonomic imbalances rather than end 
organ pathology11. In comparison to these earlier studies, QTVI in the current study was 
not different between AB individuals and those with autonomically incomplete SCI  
during supine rest. The fact that there were no differences in responses between the 
groups may very well be confounded by the inability to detect a difference between two 
groups with such a low n and low statistical power. However, another postulate is that 
although autonomic physiology is altered following incomplete SCI, there may not be a 
difference in QTVI responses between AB individuals and those with autonomically 
incomplete SCI. This postulate is supported by results from Ravensbergen et al. (2012) 
who demonstrated that individuals with autonomically incomplete SCI and AB controls 
have similar QTVI responses15. The preservation of cardiac autonomic function in the 
current SCI cohort was evidenced by the SCI participants showing a relative maintenance 
of blood pressure during the CV stress condition, and the HR responses to the different 
conditions were similar in both groups (Table 3). This suggests intact central command of 
cardiovascular functions in the SCI, which points at maintenance of autonomic integrity. 
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However, larger scale invasive studies are warranted to confirm that QTVI responses are 
similar between AB and autonomically incomplete SCI because the only available 
evidence for this speculation is from studies during resting conditions only 
(Ravensbergen et al., 2012)15 and low sample size (current investigation).      
Currently, HRV plays an important role in evaluating cardiac autonomic activity, 
and can identify autonomic responsiveness in AB and SCI individuals under different 
autonomic states19. The current study is a further analysis of previously collected ECGs, 
by our group, that evaluated HRV as an index of cardiac autonomic function in 
individuals with incomplete SCI19.  Specifically, we showed from frequency domain 
analysis of HRV that HF power was almost completely abolished after atropine 
administration, suggesting its role as a surrogate for cardiac parasympathetic outflow. 
Further, metoprolol administration during CVS resulted in LF:HF ratio reduction, 
suggesting that the ratio may be representative of cardiac sympathovagal balance in 
individuals with incomplete SCI. It is clear from the current investigation that the QTVI 
is also influenced by similar alterations in autonomic activity, however, it is still 
uncertain which method better reflects cardiac autonomic activity in individuals with 
incomplete SCI, and warrants further investigation. Results from this study are in 
agreement with previous work suggesting that QTVI is an index of sympathetic activity 
at times of elevated CV stress. This was shown by the increase in QTVI during CV stress 
and its subsequent reduction after metoprolol administration. It is possible that the 
increase in QTVI that was seen when moving from the supine position to CV stress was 
due to vagal withdrawal, rather than sympathetic activation. However, this is unlikely, as 
subsequent β-blockade reduced the QTVI back to values that were similar to baseline. 
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Thus, during times of autonomic arousal, increases in the QTVI are more reflective of 
sympathetic activity per se, rather than vagal withdrawal. In agreement with these 
findings, a recent report by Baumert et al. (2011) showed elevated QT variability only in 
hypertensive patients, who have increased sympathetic tone, but not in healthy resting 
subjects11. Similarly, Piccirillo et al. (2009) found no correlation between QTVI and 
integrated stellate ganglionic nerve activity in dogs at baseline, but after inducing 
congestive heart failure, QTVI and stellate ganglionic nerve activity were significantly 
correlated. These reports, in addition to the current study, agree that QTVI seems to 
reflect cardiac sympathetic outflow during times of elevated sympathetic activity10.   
 The current investigation also suggests that QTVI may be inversely related to 
cardiac vagal outflow, but only at times of rest. This was evidenced by an increase in 
QTVI during supine rest after administration of atropine. These results are in agreement 
with previous findings from Piccirillo et al. (2009), who demonstrated a negative 
correlation between QTVI and integrated vagal nerve activity in dogs at rest10. However, 
after inducing congestive heart failure, there was no correlation between the two 
variables. Further, in a recent study on individuals with SCI, La Fountaine et al. (2011) 
reported elevated QTVI values in individuals with tetraplegia compared to able-bodied 
controls during supine resting condition, which was attributed to an attenuated cardiac 
autonomic outflow in the SCI group11. Furthermore, the authors found a negative 
correlation between HF power and QTVI, and there is strong evidence that HF  power is 
a valid index of parasympathetic cardiac control after SCI19,25,26. Therefore, it appears 
that QTVI is influenced by both sympathetic and parasympathetic outflow to the heart, 
depending on the dominating system. As stated by Berger (2009) with regards to 
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autonomic influence on QTVI, when multiple factors influence a physiological variable, 
the correlation between any one input and the output variable is highest when the strength 
of that input rises above all others, and fades when that input becomes overwhelmed by 
the others27. Accordingly, when the parasympathetic nervous system is dominant (at rest), 
it is inversely reflected by the QTVI, but when the sympathetic nervous system is 
dominant at times of CV stress, it is directly reflected by the QTVI. It is also important to 
note that although the QTVI is undoubtedly influenced by cardiac autonomic function in 
individuals with incomplete SCI, it is not necessarily a clean measure of cardiac 
autonomics, as it is still unknown if the QTVI is influenced equally by cardiac 
sympathetic and parasympathetic activity. Therefore, further studies are warranted in 
order to elucidate the ability of the QTVI to quantify cardiac sympathetic and 
parasympathetic activity in individuals with SCI.   
 Because the QT interval is influenced by HR, the RR-interval is also a major 
determinant in the QTVI calculation. Accordingly, the QTVI can increase from either 
increases in QT variability, or decreases in RR variability. Results from the current study 
show that during the sympathetically induced increase in QTVI, there was a concomitant 
increase in QTv but no change in RRv. In contrast, during the resting supine conditions, 
RRv significantly decreased in response to atropine administration while no change 
occurred in QTv. This suggests that sympathetic influence on QTVI may occur through 
increasing QT variability, whereas vagal influence on QTVI may occur through 
decreasing HR variability. This is in agreement with findings from Piccirillo et al. (2009) 
who showed that during resting conditions, there was a negative correlation between RRv 
and cardiac vagal outflow. After inducing congestive heart failure however, there was a 
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strong relationship between QTv and integrated stellate ganglionic nerve activity10. 
Similarly, Mine et al. (2008) showed a decrease in QT variability after propranolol 
administration with no change in RR interval21. The authors reported that sympathetic 
influence on QT variability does not require changes in the RR interval, and may occur 
by an alternate, more direct mechanism, such as QT variability. Taken together, these 
reports suggest that at rest, vagal modulation of QTVI may occur through changes in HR, 
while sympathetic activity influences QTVI through changes in QT variability.    
Limitations: 
 The main limitation to the current study is the small sample size and high 
variability within participants, however, all participants responded similarly to the 
autonomic blockade in terms of its influence on QTVI. In addition, the fact that there 
were no significant differences in QTVI between groups may be due to the low sample 
size. Therefore, larger scale studies are warranted to confirm these results. The second 
limitation to the study was that the order of drug administration was not randomized and 
only one order of drug administration was used (metoprolol followed by atropine). 
Therefore, we cannot comment on the effects of atropine alone on QTVI. Due to the 
preliminary nature of this study, and the invasiveness of the testing, the authors felt that a 
second day of drug administration was not justified. However, in the supine position, the 
administration of metoprolol has no significant effect on the QTVI, and thus, it did not 
likely confound the effects observed with subsequent atropine administration. Still, 
further research is required to shed light on this issue. The third limitation to the study 
was the high range of years post injury, however, there is no current evidence suggesting 
a degenerative/progressive change in cardiac autonomic regulation during the chronic 
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stages of incomplete SCI, and therefore the wide range of years post injury was likely not 
a confounder. Another limitation to the study was that only individuals with 
autonomically incomplete SCI were included, and therefore, these results cannot be 
generalized to all SCI cases, as those with complete loss of autonomic control are likely 
to show an attenuated response to CVS and thus, would provide great insight on the value 
of QTVI in the SCI population. However, a large portion of the SCI population includes 
those with incomplete injuries, therefore, the results from the current are clinically 
relevant for many individuals with SCI.      
Conclusions: 
 The QTVI appears to be influenced by both sympathetic and parasympathetic 
cardiac regulation depending on the state. At times of elevated CV stress, the QTVI 
seems to reflect the increase in sympathetic outflow, whereas during resting conditions, 
the QTVI seems to be inversely reflective of vagal outflow. Further, the relationship 
between QTVI and autonomic cardiac control appears to be maintained after 
autonomically incomplete SCI.  
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Abstract:  
Purpose: To examine the day-to-day reproducibility of the QT-variability index (QTVI) 
and the QT-apex variability index (QTaVI) in individuals with spinal cord injury (SCI). 
Methods: Ten individuals with SCI participated in the current study (C2-T10; AIS A-D; 
8.6 ± 7.8 years post injury). On two occasions, with a 10-day interval, a 10-minute resting 
electrocardiogram was obtained from each participant. The QTVI and QTaVI were 
analyzed from 256 electrocardiographic beats from all participants, and a separate 
analysis was performed on those with injuries above the 4th thoracic level. An intraclass 
correlation coefficient (ICC) test was performed to measure day-to-day reproducibility of 
these measures and a Bland-Altman test was performed on all participants in order to 
examine the skewness of the measures.  
Results: The reproducibility values were found to be high for both the QTVI (all 
participants: R=0.892; above T4: R=0.893) and the QTaVI (all participants: R=0.908; 
above T4: R=0.915). In addition, the reproducibility of QTVI and QTaVI did not appear 
to be skewed as indicated by Bland-Altman plots.  
Conclusion: Both the QTVI and the QTaVI may be used as reproducible means of 
assessing cardiac autonomic function in individuals with SCI. Further, a reduction in 
cardiac sympathetic regulation after high thoracic and cervical level SCI does not appear 
to influence the day-to-day reproducibility of these measures.     
 
Keywords: Spinal cord injury, electrocardiogram, autonomic function, QT-interval.   
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Introduction: 
 
It is well documented that spinal cord injury (SCI) results in complete or partial 
loss of supraspinal control of the cardiovascular system, which therefore increases the 
risk for cardiovascular dysfunctions and mortality1. Specifically, injuries above the 5th 
thoracic level (T5) may lead to compromised cardiac sympathetic innervation, which 
increases the susceptibility to cardiac arrhythmias2-4 and reduces exercise tolerance5. In 
addition, studies have reported a reduction in cardiac parasympathetic outflow following 
SCI, believed to be partly attributed to a physiological adaptation in an attempt to 
maintain sympathovagal balance6,7. However, such a reduction in cardiac vagal outflow 
may be problematic, as it has been demonstrated through a wide range of indicators that 
reduced vagal activity is associated with increased risk of mortality and morbidity, 
independent of traditional risk factors8. Furthermore, the loss of supraspinal control over 
sympathetic preganglionic neurons that innervate the vascular bed is associated with both 
autonomic dysreflexia (characterized by episodic fluctuations in blood pressure)9 and 
orthostatic hypotension, which may reduce functional capacity and the ability to engage 
in activities of daily living. Thus, it is imperative to develop reliable, non-invasive 
measures of cardiac autonomic activity in individuals with SCI in order to assess the 
integrity of cardiac autonomic regulation and potential changes over time. 
Several electrocardiogram (ECG)-based measures have been employed for non-
invasive assessment of cardiac autonomic regulation after SCI, including spectral analysis 
of heart rate variability (HRV) and non-linear HRV. Although both measures have been 
shown to be reproducible in individuals with SCI10,11, not all parameters achieve that 
status, as high frequency power was shown to have poor reproducibility in this 
75 
 
 
 
population10. In addition, the efficacy of some of these parameters in gauging cardiac 
sympathetic activity in the SCI population remains questionable12,13. More recently 
however, the QT-variability index (QTVI) has been developed as a non-invasive measure 
of beat-by-beat repolarization variability14. This measure takes simultaneous QT and RR 
intervals into consideration, thus providing insight on both myocardial (QT-interval) and 
autonomic (RR-interval) activity. An elevation in QTVI suggests more repolarization 
variability, while a reduction in QTVI suggests more stable and less variable 
repolarization time. An increase in QTVI has been strongly associated with future cardiac 
events15,16, hypertension17, cardiac arrhythmias18 and heart failure19. In addition, it is also 
augmented in non-pathological settings that are associated with changes in cardiac 
autonomic activity, such as aging20 and exercise21. In addition, the QTVI has been shown 
to be moderately reproducible in healthy humans22 and patients with kidney failure23.    
The QTVI has been shown to be elevated in individuals with SCI24, especially 
those with injuries above T5 and/autonomically complete injuries4. A recent study from 
our laboratory has demonstrated the QTVI’s ability to reflect both cardiac sympathetic 
and parasympathetic activity in individuals with tetraplegia25. Although the QTVI is a 
relatively novel method, it may be a promising method for gauging the amount of 
preserved cardiac autonomic function in individuals with SCI. However, autonomic 
decentralization following SCI may cause the cardiovascular system to operate on 
reflexes alone, rather than well regulated supraspinal signals. Hence, because the QTVI is 
highly influenced by cardiac autonomic activity20,26, autonomic decentralization may 
render the QTVI unstable. Therefore, before the QTVI can be effectively employed as a 
measure of cardiac autonomic activity in individuals with SCI, its reproducibility must be 
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examined in this population. Accordingly, the purpose of this study was to examine the 
day-to-day reproducibility of the QTVI in individuals with SCI.  
Methods: 
 
Participants: 
Electrocardiographic data from 10 individuals (6 male, 4 female; age 44.8 ± 15.0 
years) with SCI (C2-T10; AIS A-D; 8.6 ± 7.8 years post-injury) were collected and 
analyzed for this study. Participant characteristics can be found in Table 1. All 
participants were at least 1 year post injury and were recruited from a community based 
rehabilitation program for individuals with SCI (Power Cord, St. Catharines, Ontario). 
All participants were medically examined and had no existing cardiovascular disease or 
cardiac pacemakers, and other than the SCI, they were healthy and free from secondary 
health compilations.  
Table 1: Participant Characteristics  
AIS: ASIA Impairment Scale, where ASIA stands for the American Spinal Injury 
Association. 
 
Participant Gender Age 
Injury 
Level 
AIS 
Classification 
Years Post 
Injury  
1 M 21 C7 B 4 
2 F 37 T3 A 18 
3 M 41 C6 B 5 
4 M 65 C5 D 5 
5 M 67 C2 B 3 
6 F 43 C7 C 9 
7 F 45 C7 A 8 
8 F 27 T6 A 6 
9 M 44 T6 A 27 
10 M 58 T10 A 5 
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Study Protocol:  
Each participant visited the laboratory on two occasions (Day 1 and Day 2) within 
a 10-day period, and no two testing sessions were less than seven days apart. All testing 
sessions took place between the hours of 12pm and 4pm, and each participant was tested 
at the same time of day during both visits. Participants were asked to refrain from any 
alcohol consumption or smoking 24 hours prior to testing and to avoid caffeine intake the 
morning of testing. In addition, any types of exercise, aside from morning stretches, were 
to be avoided 24 hours prior to testing and each participant was at least 1 hour post-
prandial during data collection. Medications were not discontinued during data collection, 
however, participants were instructed to maintain the same dosage during both days of 
testing. Medications that participants were on during data collection included baclofen, 
senokot, midodrine and fludrocortisone. All participants were asked to empty their urine 
bags, bladders or bowels before arriving to the laboratory.  
Upon arriving to the laboratory, participants were transferred onto a plinth and a 
single lead ECG (lead 2) was connected. Before data collection took place, the lights in 
the laboratory were dimmed and each participant was asked to lie down quietly in the 
supine position for 10 minutes in order for the participants to be in an autonomically 
relaxed state. Following 10 minutes of rest, 10 minutes of continuous ECG recordings 
were collected for later analysis of the QTVI (Power Lab, Lab Chart 7, ADInstruments). 
All ECG data were collected at a sampling frequency of 1000Hz and a band-pass filter of 
0.5-50Hz was used in order to eliminate both high frequency noise and baseline wander, 
which can influence QT interval analysis.   
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QT Interval Analysis: 
Two hundred and fifty six stable artifact free beats were used for QTVI analysis 
for each participant. The QT interval was analyzed in 2 ways: i) from the onset of the Q 
wave to the intersection point of the isoelectric line and the tangent line down the 
descending limb of the T-wave, and ii) from the onset of the Q wave to the apex of the T-
wave. The latter analysis, known as QTaVI17 is easier to detect and is less corrupted by 
noise compared to the end of the T-wave. The QTaVI method has been employed in 
assessing beat-to-beat repolarization variability in able-bodied27 and SCI individuals28.   
Prior to further analysis, each beat was visually examined in order to ensure that 
the software marked the QT and QT-apex intervals appropriately. The QTVI was 
calculated using the following formula developed by Berger et al14:  
QTVI = Log10 [(QTv/QTm
2) / (RRv/RRm2)]  
where, QTv is the QT interval variance, QTm2 is the mean QT interval squared, RRv is 
the RR interval variability and RRm2 is the mean RR interval squared.  
The QTaVI was calculated using the formula:  
Log10 [(QTav/QTam
2) / (RRv/RRm2)] 
where, QTav is the QT-apex interval variance and QTam2 is the QT-apex interval mean 
squared, RRv is the RR interval variability and RRm2 is the mean RR interval squared. 
Statistical Analysis: 
 A dependent sample t test was performed on all participants (n=10) in order to 
compare Day1 and Day2 values for QTVI, QTaVI, RR interval and variability, QT 
interval and variability, as well as QT-apex interval and variability. Statistical 
significance was set at p <0.05 and data are reported as means ± standard deviations. To 
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calculate the test:retest reproducibility of QTVI and QTaVI, 2-way mixed model intra-
class correlations (ICC) were performed for all participants (n=10). Separate ICC’s were 
also calculated for participants with injury levels above T4 (n=7), as such injuries are 
associated with a greater loss of control over cardiac function due to compromised 
cardiac sympathetic innervation. In addition, Bland-Altman plots were performed for 
QTVI and QTaVI in order to assess possible skewness of the data, ie, to determine if day 
to day differences depend on the magnitude of the QTVI or QTaVI values. All statistical 
analysis was performed using SPSS version 20 (SPSS Inc, Chicago).     
Results: 
 
QTVI and QTaVI Measures: 
The t test revealed no significant differences between Day 1 and 2 values for 
QTVI (-1.38±0.62 vs. -1.37±0.57; p=0.93) and QTaVI (-1.33±0.48 vs. -1.24±0.38; 
p=0.33). Intraclass correlation coefficients showed high reproducibility across all subjects 
for both QTVI and QTaVI (Table 2). When assessing only participants with injury level 
above T4, ICC’s were also very high for QTVI and QTaVI (Table 2).  
Table 2: Reproducibility of QTVI and QTaVI  
  Day 1 Day 2 R 
All participants (n=10)       
QTVI  -1.38±0.62 -1.37±0.57 0.892* 
QTaVI  -1.33±0.48 -1.24±0.38 0.893* 
Injury Above T4 (n=7)       
QTVI  -1.35±0.73 -1.19±0.57 0.908* 
QTaVI  -1.31±0.58 -1.18±0.43 0.915* 
 
QTVI: QT variability index; QTaVI: QT- apex variability index; R Intraclass correlation 
coefficient. Day 1 and Day 2 are expressed as means ± S.D. *denotes significant 
intraclass correlation (p < 0.05).  
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The reproducibility of QTVI and QTaVI did not appear to be skewed as indicated by 
Bland-Altman plots (Figures 1 & 2). Thus, the reproducibility of these measures do not 
appear to depend on the actual value of the measure.  
 
Figure 1: Bland-Altman Plot for QTVI
 
QTVI: QT-variability index 
Figure 2: Bland-Altman Plot for QTaVI 
 
QTaVI: QT-apex variability index  
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T-tests were also performed to compare Day 1 and Day 2 values for RR interval, RR 
variability, QT interval, QT variability, QTa interval and QTa variability and the results 
showed no significant differences between the two days for any of these variables (Table 
3).  
 
Table 3. Day to day values for electrocardiographic parameters 
 
 
 
 
 
  QTa: QT-apex interval. 
 
 
Discussion: 
 
The main finding of the current study is that both QTVI and QTaVI were found to 
be highly reproducible in individuals with SCI. The reproducibility was evident when all 
participants were considered as a whole, as well as when individuals with injury levels 
above T4 were analyzed separately. Therefore, it appears that spinal lesions that may 
compromise cardiac sympathetic outflow do not adversely influence the reproducibility 
of the QTVI and QTaVI. Previous investigators have suggested ICC to be considered 
“good” if it ranged between 0.60 and 0.81 and almost perfect if exceed 0.8129, while other 
investigators have suggested values need be a minimum of 0.81 to be considered 
 Day 1 Day 2 p-Value 
RR interval (ms)   1005.88±144.8 1002±115.08 0.93 
RR Variance 2362.54±1662.73 2327.24±2073.86 0.95 
QT Interval (ms) 372.31±25.43 373.81±23.74 0.80 
QT Variance 13.77±14.33 9.90±5.65 0.41 
QTa Interval(ms) 309.38±25.07 310.63±21.95 0.81 
QTa Variance 10.72±13.17 8.87±3.74 0.65 
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trustworthy30.  The ICC values of the present study exceeded these suggested values with 
correlation coefficients ranging from 0.89 to 0.91.         
 Cardiovascular disease is a growing concern in the SCI population as it is the 
leading cause of mortality in this population1. The onset of cardiovascular dysfunctions 
manifests much earlier in the SCI population compared to able-bodied individuals and 
progresses at a more rapid rate. Loss of or blunted cardiovascular autonomic control 
following SCI is a possible explanation for the elevated risk for cardiovascular 
dysfunctions in this population. For example, injuries above the mid thoracic region have 
been associated with a reduction in both cardiac sympathetic and parasympathetic 
outflow6. The former is a result of disruption in the supraspinal cardiac sympathetic 
modulation, while the latter is likely a result of the profound physical inactivity 
associated with SCI. Furthermore, the reduced supraspinal control of sympathetic activity 
may result in potentially dangerous autonomic conditions such as autonomic dysreflexia, 
orthostatic hypotension and cardiac arrhythmias. Accordingly, there is a need for reliable 
methods to gauge cardiac sympathetic and parasympathetic integrity as a way to 
determine how much damage has been sustained to the autonomic nervous system and 
how much it improves or changes over time. 
One such measurement tool, the QTVI, has been shown to reflect cardiac 
autonomic activity in several clinical populations14,17, and healthy individuals26. In 
addition, individuals with SCI have been reported to exhibit higher QTVI values 
compared to healthy able bodied individuals4,26. Recently, our group demonstrated that 
QTVI may reflect both cardiac sympathetic and parasympathetic activity in individuals 
with autonomically incomplete injuries25. The ICC values for both the QTVI and QTaVI 
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obtained from the current study were shown to be higher than previously reported values 
for HRV in individuals with SCI.  Ditor et al. reported ICC scores of 0.84 and 0.82 for 
low frequency and low to high frequency ratio, respectively10. Although it is not clear as 
to why QTVI seems to be more reproducible than HRV, it could be because the QTVI is 
influenced by 2 factors: QT variance (numerator) and RR variance (denominator) (see 
formula). As such, if QTVI were to increase, this could be due to either an elevation in 
QT variance or a reduction in RR variance. Thus, if RR variability is subjected to day-to-
day changes10, this could be countered by the stability of QT variance. It is worth noting 
that non-linear measures of HRV, which are only derived from the RR interval, have 
produced higher ICC values compared to the QTVI from the current investigation11. 
However, the efficacy for non-linear HRV to reflect cardiac autonomic function in 
individuals with SCI is unclear13, whereas the QTVI may hold more promise in that 
aspect25.   
Previous investigations reported moderate reproducibility for QTVI in healthy 
individuals22 and patients with kidney failure23. It is interesting to note that although renal 
failure patients had significantly higher QTVI values compared to their healthy 
counterparts, both groups showed comparable reproducibility23. This suggests that the 
amount of ventricular repolarization variability per se may not influence QTVI 
reproducibility. Reproducibility of the QTVI may be more influenced by methodological 
techniques of measuring the QT-interval rather than physiological factors. Unpublished 
data from our laboratory suggest that the method of analyzing the QT-interval has a 
significant effect on the QTVI. In addition, Gao et al. (2005) reported that their results 
may be influenced by the algorithm used, as it was difficult to properly define QT-
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intervals on morphologically abnormal ECGs23. However, further research with a bigger 
sample size is warranted to confirm our results of highly reproducible QTVI in the SCI 
population.     
Conclusion: 
This is the first study to demonstrate that QTVI and QTaVI are reproducible in 
individuals with SCI, and this high degree of reproducibility also persists in individuals 
with injury levels above T4. Therefore, measures of QTVI should be employed in future 
research as a means of assessing cardiac autonomic function in individuals with SCI.  
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Abstract: 
Objective: To examine the relationship between resting cardiac autonomic function and 
left ventricular diastolic function in able-bodied and spinal cord injured (SCI) individuals. 
To determine the autonomic and diastolic responses to vagal stimulation via the cold face 
test (CFT) in both groups.  
Methods: Thirteen SCI (Age: 41±8.5; 10 males, 3 females) and 12 able-boded (AB) 
individuals (Age: 40±8.5; 9 males, 3 females) without history of cardiovascular disease 
participated in the study. Baseline cardiac parasympathetic function was assessed from a 
5-minute electrocardiographic (ECG) epoch via heart rate variability (HRV) and the QT-
variability index (QTVI). This was followed by assessment of baseline LV ventricular 
function by conventional echocardiography. In order to assess autonomic responses to 
vagal stimulation, 1-minute ECG data was collected before and during the CFT, and in 
order to assess diastolic response to vagal stimulation, LV diastolic function was assessed 
immediately at the end of the CFT.  
Results:  At baseline, the able-bodied group showed strong correlations between early 
diastolic filling and cardiac parasympathetic activity, as shown by SDNN (r=0.61; 
p=0.03), RMSSD (r=0.75; p=0.003), coefficient of variance (r=0.61; p=0.03) and the 
QTVI (r=-0.60; p=0.03). These relationships however were absent in the SCI group, as 
there were no significant correlations between any of the parameters. During the CFT, the 
able-bodied group experienced a significant reduction in heart rate (p<0.05) as well as a 
significant increase in HRV (p<0.05). In contrast, the SCI group exhibited strong trends 
for elevated HRV, but no change in heart rate during the CFT (p>0.05). Moreover, the 
able-bodied group showed positive correlations between an increase in HRV and diastolic 
filling during the CFT (p<0.05), while the SCI group showed a positive correlation 
between an increase in HRV and deceleration time (p<0.05).  
Conclusion: Parasympathetic activity plays a role in modulating diastolic function at 
rest, however, this relationship seems to be lost following SCI. In addition, the increase in 
cardiac vagal activity during the CFT results in atypical heart rate and diastolic responses 
in those with SCI.    
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Introduction: 
 
Left ventricular (LV) diastolic function is governed by the combined effects of 
factors such as loading conditions1,2, LV elasticity3,4, LV morphology and cardiac 
autonomic function5. When all of these factors operate concomitantly in a harmonious 
fashion, the LV is able to rapidly and passively fill with blood during early diastole, and 
continue to fill with blood via atrial contraction during late diastole. Alterations in any of 
the aforementioned factors can disturb diastolic filling and thus, may increase the risk for 
further cardiac complications5. The autonomic nervous system plays a role in maintaining 
normal cardiac function, as it is well established that the heart is constantly operating 
under the balance of sympathetic and parasympathetic activity6. Although the literature 
on autonomic-diastolic interactions is scarce, there is evidence suggesting that cardiac 
autonomic function may play a role in orchestrating LV diastolic function7-10. Previous 
studies have shown that a reduction in indices of cardiac parasympathetic activity are 
correlated with diastolic impairments in patients with diabetes11,12  and heart disease13. In 
addition, experimental animal studies have shown that LV diastolic impairments manifest 
at approximately the same time as when cardiac parasympathetic regulation begins to 
deteriorate14. Furthermore, studies in healthy humans have shown that individuals with 
lower diastolic function demonstrate lower values of heart rate variability (HRV)15. 
Finally, direct vagal stimulation in animals has been shown to increase diastolic filling in 
animals16, whereas parasympathetic withdrawal in humans has been shown to reduce 
diastolic filling7,10.   
 Spinal cord injury (SCI) is a condition well known to induce impairments in the 
autonomic regulation of the cardiovascular system. This is mainly attributed to the 
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reduction, or loss, of supraspinal control of descending sympathetic signals that modulate 
cardiovascular activity17. Although the vagus nerve is not directly influenced by SCI, as it 
exits from the brainstem, individuals with SCI still demonstrate alterations in cardiac 
parasympathetic activity. Non-invasive measures have shown that individuals with SCI 
demonstrate altered chronotropic responses to cardiac vagal activity18,19. For example, 
vagal withdrawal resulted in a blunted HR response in those with SCI18, whereas non-
invasive cardiac vagal stimulation resulted in paradoxical tachycardia19. It is unknown if 
such chronotropic impairments in response to autonomic activity extend to impairments 
in mechanical relaxation of the heart as well. However, since diastolic function appears to 
be influenced by cardiac parasympathetic activity, one could hypothesize that alterations 
in cardiac parasympathetic activity would result in altered diastolic function as well.  
 The cold face test (CFT) is an assessment based on the diving reflex, and is a 
method of assessing the integrity of the trigeminal-brainstem-vagal pathway. It is non-
invasive, requires minimal active participant cooperation and is time efficient, thus 
making it a favorable autonomic test. The typical cardiac response to the CFT is 
pronounced bradycardia due to enhanced cardiac parasympathetic outflow20,21. Therefore, 
the CFT may be employed to non-invasively examine the interaction between changes in 
cardiac vagal activity and LV diastolic function in able-bodied and SCI individuals. 
Accordingly, this is an exploratory study aiming to examine 1) the relationship between 
resting cardiac parasympathetic activity and LV diastolic function in able-bodied and SCI 
individuals at rest, 2) and LV diastolic changes in response to cardiac parasympathetic 
stimulation via the CFT in able-bodied and SCI individuals.  
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Methods: 
 
Participants: 
 Twelve able-bodied individuals and 13 individuals with SCI (C4-T5; AIS A-D; 
16.5±9.7 years post injury) participated in this study. Both groups were matched for age, 
sex and body mass. None of the participants had a history of cardiovascular disease, and 
all had normal resting and exercise electrocardiograms (ECG). Participants from both 
groups included individuals with habitual activity ranges from sedentary to physically 
active and none were highly trained or competitive athletes. Participants provided 
informed consent to participate in the study, which was approved by the Brock University 
Biosciences Research Ethics Board.  
Study Protocol:  
 All participants were requested to void their bladder and bowel prior to testing in 
order to reduce the risk of any sympathetic influence on the experiments. Body mass (kg) 
and height were measured and from this body mass index (BMI: kg/m2) was calculated. 
All medications for individuals with SCI were taken as prescribed during the day of 
testing. Medications that the participants were taking included baclophen for muscle 
spasms as well as anti-diuretics and alpha agonists for hypotension. Participants were in 
the left lateral decubitus position during the pre-test resting period as well as throughout 
the testing as changes in body position can alter cardiac autonomic activity22. Participants 
first rested in the left lateral decubitus position in a quiet, dim room for 10 minutes while 
breathing at 15 breaths/min as paced with a metronome. Following 10 minutes of rest, 5 
minutes of baseline ECG data were collected for later analysis of baseline cardiac 
parasympathetic activity. Following baseline ECG collection, LV diastolic function was 
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assessed via echocardiography. Continuous ECGs were then recorded immediately before 
(Pre-CFT) and during the CFT in order to assess changes in cardiac parasympathetic 
activity. The cardiac probe was placed on the apical window throughout the CFT in order 
to keep the 4-chamber apical view in sight for immediate assessment of diastolic function 
at the termination point of the CFT.  
Cardiac Autonomic Activity:    
 Baseline cardiac parasympathetic activity was measured from the 5 minutes of 
ECG data collected prior to the baseline cardiac imaging. A Single-lead (lead II) ECG 
was used for the collection of continuous HR for later analysis of cardiac parasympathetic 
activity (Power Lab, Lab Chart 7, AD Instruments). The ECG signal was sampled at a 
frequency of 1000 Hz, and a band-pass filter of 0.5-50 Hz was applied in order to 
eliminate signal corruption by high frequency noise and baseline wander23. None of the 
participants showed any arrhythmias before, during, or after, the CFT. The ECG signal 
was analyzed for both frequency and time domain HRV indices of parasympathetic 
regulation. Frequency domain measures included the natural log of the high frequency 
component of HRV (HFln), while time domain measures included the standard deviation 
of continuous RR intervals (SDNN), the root mean square of differences between RR 
intervals (RMSSD) and coefficient of variance (CV). In addition, cardiac 
parasympathetic activity was measured via the QT-variability index (QTVI)24, which was 
calculated in accordance to the Berger formula25 (Berger et al., 1997):   
QTVI = Log10 [(QTv/QTm
2) / (RRv/RRm2)]  
where, QTv is the QT interval variance, QTm2 is the mean QT interval squared, RRv is 
the RR interval variance and RRm2 is the mean RR interval squared.  
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Echocardiography: 
All echocardiographic images were obtained using a commercially available 
ultrasound system (Vivid Q; GE Vingmed Ultrasound AS, Horten, Norway) with a 1.5-
MHz phased-array transducer. All images were acquired by a single experienced 
sonographer and were stored for later offline analysis using a commercially available 
software (EchoPac version 6.0; GE Vingmed Ultrasound AS). Imaging was performed 
while participants were in the left lateral decubitus position at end expiration and 3 
consecutive cycles were stored for later analysis. Measures of diastolic function were 
calculated from the average of the 3 consecutive heart cycles.  
 Pulse-wave Doppler was used to assess diastolic function according to the 
recommendation of the American Society of Echocardiography26. For mitral inflow 
velocity, from an apical 4-chamber view, a 4 mm sample volume was placed between the 
mitral valve leaflet tips during diastole. The Doppler velocity curves were digitized to 
obtain peak early (E) and late (A) mitral flow velocities, and their ratio (E:A) was 
calculated, where a higher ratio illustrates greater reliance on early diastole, and a lower 
ratio depicts greater reliance on atrial contraction. The descending limb of the E wave 
was used to measure deceleration time (DT). 
Cold Face Test: 
 Packs of ice-water slush (1.2 C˚) were placed on the forehead and bilateral 
maxillary areas for 1 minute. Care was taken to avoid the eyes in order to prevent 
stimulation of the oculo-cardiac vagal reflex27. Participants were instructed to avoid 
holding their breath and to breathe as normally as possible throughout the test. Because 
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the test is generally uncomfortable, the participants were informed every 10 seconds 
about how much time remained and were verbally encouraged to keep breathing. In order 
to avoid the potential influence of autonomic excitement before the onset of the CFT, the 
Pre-CFT autonomic data were obtained from a 1-minute ECG recording collected 1 
minute prior to the start of the CFT, and the CFT recordings were collected during the 
minute while the cold packs were in contact with the participant’s face. Time and 
frequency domain HRV indices were used to assess changes in cardiac parasympathetic 
assessment during the CFT. However, the QTVI was not used to assess changes in 
parasympathetic activity during the CFT, as it was difficult to obtain clean ECG signals 
for QT-interval assessments during the CFT.   
Statistical Analysis: 
Unpaired t-tests were used to measure between-group differences in participant 
characteristics, as well as baseline cardiac autonomic and ventricular parameters. 
Pearson’s correlations were used to assess potential relationships between baseline 
cardiac parasympathetic activity and LV diastolic function. A 2-way repeated measure 
analysis of variance (ANOVA) was used to detect any group (controls vs SCI) by 
condition (CFT) interactions for autonomic and diastolic function and a t-test was used as 
a post-hoc when interactions were found. Cohen’s D was used to estimate effect sizes28. 
Change variables were calculated for cardiac autonomic and LV diastolic function indices 
and unpaired t-test was used to determine between group differences. Pearson’s 
correlations were used to determine relationships between the change variables in 
response to CFT. In addition, a partial Pearson’s correlation was used to determine the 
relationship between the change variables while controlling for the change in HR, as HR 
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has been shown to correlate with cardiac parasympathetic indices29. Data is presented as 
means ± standard deviation, and all statistical analyses were performed using Statistical 
Package for Social Sciences (SPSS 22) software. Statistical significance was set at 
p≤0.05.    
Results: 
 
Participants: 
 All participant characteristics are provided in Table 1. There were no between-
group differences in age, body mass or BMI. All individuals with SCI were at least 1 year 
post injury.  
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Table 1. Participant Characteristics 
AB: Able-bodied; AIS: ASIA impairment scale where ASIA stands for American Spinal 
BMI: Body mass index; Injury Association; HR: Heart rate; SCI: Spinal cord injury; YPI: 
Years post injury  
 
 
Participant 
Age 
(years) Sex 
Body 
Mass(kg) BMI(kg/m) HR(bpm) Level AIS YPI 
SCI         
1 55 M 80.7 26.8 73 C4 A 8 
2 42 M 68.2 20.8 53 C4 C 18 
3 31 F 64.0 22.7 61 C5 B 6 
4 46 M 83.0 28.7 65 T6 A 19 
5 23 M 83.2 27.8 57 C8 B 5 
6 43 M 81.0 27.1 43 C4 A 6 
7 46 F 61.0 22.7 73 C7 A 9 
8 37 M 100.0 31.6 70 C5 B 18 
9 38 M 96.4 25.9 54 C5 C 38 
10 54 M 95.0 29.3 55 C567 D 27 
11 38 F 56.0 21.1 64 T3 A 20 
12 41 M 66.0 24.2 77 T5 A 16 
13 44 M 91.0 27.2 67 T4 A 24 
AVE 41.38  78.9 25.8 62 --- --- 16.5 
SD 8  14.6 3.3 9 --- --- 9.7 
AB         
1 44 M 94.3 26.3 50 --- --- --- 
2 44 M 70.1 24.8 47 --- --- --- 
3 35 F 57.2 21.2 75 --- --- --- 
4 35 M 76.0 24.5 62 --- --- --- 
5 41 M 102.0 30.5 51 --- --- --- 
6 40 M 67.6 23.7 43 --- --- --- 
7 30 F 57.4 20.9 63 --- --- --- 
8 33 M 91.1 27.8 51 --- --- --- 
9 54 M 102.1 27.4 62 --- --- --- 
10 51 M 97.1 28.9 54 --- --- --- 
11 46 M 80.3 24.7 71 --- --- --- 
12 24 M 80.0 26.1 60 --- --- --- 
AVE 39.75  81.08 25.6 57 --- --- --- 
SD 8  16.25 2.9 9 --- --- --- 
p-value 0.64 --- 0.72 0.84 0.22 --- --- --- 
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Baseline Autonomic and Diastolic Data: 
 All baseline autonomic data are provided in Table 2. There were no between-
group differences in resting HR or any of the frequency and time domain measures of 
cardiac parasympathetic activity. In addition, there was no between-group difference in 
baseline QTVI values. Table 5 also shows that baseline diastolic parameters were not 
significantly different between the groups. Table 3 shows correlations between resting 
diastolic parameters and baseline indices of cardiac parasympathetic activity. Able-
bodied individuals demonstrated strong correlations between E and various indices of 
cardiac vagal outflow, including QTVI, SDNN, RMSSD and CV, whereas E showed a 
strong trend for a correlation with HFln. The E:A ratio was also significantly correlated 
with RMSSD and showed a trend towards a correlation with QTVI. Individuals with SCI 
only demonstrated a negative correlation between DT and CV.   
Table 2: Baseline Cardiac Parasympathetic Indices 
  AB SCI p-value 
HR 61 ± 13 62 ± 10 0.80 
HFln 5.9 ± 1.4 6.2 ± 1.3 0.53 
SDNN 55.30 ± 22.4 60.6 ± 23.1 0.56 
RMSSD 42.1 ± 22.7 48.2 ± 27.1 0.55 
CV 7.1 ± 2.2 6.4 ± 2.6 0.31 
QTVI -1.4 ± 0.3 -1.3 ± 0.7 0.72 
AB: Able-bodiedSCI: Spinal cord injury; HR: heart rate; HFln: natural log of the high 
frequency power spectrum; SDNN: Standard deviation of continuous RR intervals; 
RMSSD: Root mean square of differences between RR intervals; CV: Coefficient of 
variance; QTVI: QT-variability index 
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Table 3: Correlations between baseline cardiac parasympathetic activity and 
diastolic function.  
  AB SCI 
  E E 
QTVI r=-0.60; p=0.03* r=-0.10; p=0.79 
HFln r=0.54; p=0.06 r=0.21; p=0.50 
SDNN r=0.61; p=0.03* r=0.18; p=0.51 
RMSSD r=0.75; p=0.003* r=0.28; p=0.36 
CV r=-0.61; p=0.03* r=0.12; p=0.69 
     
  A A 
QTVI r=0.49; p=0.12 r=0.41; p=0.21 
HFln r=-0.02; p=0.96 r=0.03; p=0.92 
SDNN r=-1.55; p=0.63 r=0.24; p=0.43 
RMSSD r=-0.23; p=0.47 r=0.08; p=0.79 
CV r=0.17; p=0.59 r=-0.21; p=0.48 
     
  E:A E:A 
QTVI r=-0.54; p=0.06 r=-0.33; p=0.33 
HFln r=0.15; p=0.62 r=0.13; p=0.66 
SDNN r=0.36; p=0.23 r=-0.05; p=0.86 
RMSSD r=0.70; p=0.01* r=0.11; p=0.72 
CV r=-0.31; p=0.31 r=0.31; p=0.31 
     
  DT DT 
QTVI r=-0.15; p=0.63 r=0.20; p=0.56 
HFln r=0.10; p=0.75 r=-0.19; p=0.53 
SDNN r=0.18; p=0.55 r=-0.28; p=0.35 
RMSSD r=0.13; p=0.68 r=-0.11; p=0.71 
CV r=-0.31; p=0.34 r=-0.60; p=0.04* 
*denotes significant correlation (p≤0.05); AB: Able-bodied; SCI: Spinal cord injury; 
QTVI: QT-variability index; HFln: Natural log of the high frequency power spectrum; 
SDNN: Standard deviation of continuous RR intervals; RMSSD: Root mean square of 
differences between RR intervals; CV: Coefficient of variance; E: Early transmitral 
velocity; A: Late transmitral velocity; E:A: Ratio of early to late transmitral velocity; DT: 
Deceleration time.  
 
Diastolic-Autonomic Function in Response to the CFT.  
All autonomic changes in response to the CFT are presented in Table 4. There 
was a significant group by condition (CFT) interaction for all the autonomic measures, 
demonstrating that the two groups responded differently to the CFT. The able-bodied 
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group demonstrated the typical autonomic responses to the CFT, which included a 
significant reduction in HR, and an increase in vagal cardiac outflow as shown by 
significant increases in HFln, SDNN, RMSSD, and CV. In contrast, the SCI group did 
not show any changes in HR or HFln, but did show a trend for increased SDNN, RMSSD 
and CV. In addition, the SCI group showed large effect sizes for the indices of cardiac 
parasympathetic indices. Furthermore, compared to the SCI group, the able-bodied group 
showed greater change in HR, HFln, SDNN, RMSSD and CV in response to the CFT.   
Table 4: Cardiac vagal response to the CFT 
  Pre-CFT CFT 
p-
Value  
Cohen's' D Change 
p-value (for 
change) 
HR             
AB  64 ± 13 56 ± 13* 0.002 2.67 -8 ± 8^ 
0.005 
SCI  64 ± 11 65 ± 13 0.58 0.31 1 ± 8 
 HFln        
AB  5.9 ± 1.3 8.4 ± 2.2* 0.0001 0.74 2.5 ± 1.8^ 
0.002 
SCI  6.2 ± 1.3 6.8 ± 1.9 0.12 1.01 0.6 ± 1.4 
 SDNN        
AB  70.3 ± 30 244.6 ± 239* 0.02 0.3 175 ± 232^ 
0.02 
SCI  58.1 ± 24 85 ± 55 0.07 1.19 27.1 ± 49 
 rMSSD        
AB  47.8 ± 32.9 199.5 ± 217.1* 0.02 0.42 
152.7 ± 
209.4^ 0.03 
SCI  46.7 ± 23.8 71.9 ± 59.8 0.07 1.19 25.2 ± 44.9 
 CV        
AB  7.4 ± 3.0    16.5 ± 1.0 * 0.005 0.57 9.2 ± 9.4 ^ 
0.02 
SCI  6.2 ± 2.7 8.7 ± 5.2  0.08 1.10 2.5 ± 4.8 
 * denotes significantly different than Pre-CFT (p≤0.05); ^ denotes significantly different than 
SCI (p≤0.05); Pre-CFT: Pre cold face test; CFT: Cold face test; AB: Able-bodied; SCI: Spinal 
cord injury; HR: Heart rate; HFln: Natural log of high frequency; SDNN: Standard deviation of 
continuous RR intervals; RMSSD: Root mean square of differences between RR interval; 
CV: Coefficient of variance.  
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All LV diastolic data in response to the CFT are presented in Table 5. There were 
no group by condition interactions in any of the parameters, and no changes to any mean 
diastolic values in response to the CFT in both groups.   
Table 5: Left Ventricular Diastolic Function in response to the CFT.  
  Pre-CFT CFT 
p-value 
(Interaction) 
Change 
p-value (for 
change) 
E           
AB  0.74 ± 0.1 0.71 ± 0.1 
0.51 
-0.02 ± 0.1 
0.41 
SCI  0.75 ± 0.1 0.70 ± 0.1 -0.05 ± 0.09 
A       
AB  0.38 ± 0.1 0.41 ± 0.1 
0.76 
0.03 ± 0.1 
0.54 
SCI  0.44 ± 0.1 0.44 ± 0.1 0.00 ± 0.1 
E:A       
AB  2.1 ± 0.6 1.8 ± 0.6 
0.72 
 -0.2 ± 0.7 
0.81 
SCI  1.8 ± 0.6 1.7 ± 0.5 -0.1 ± 0.4 
DT       
AB  203.4 ± 66.2 208.8 ± 72.1 
0.56 
5.4 ± 51.1 
0.56 
SCI  199.8 ± 41.6 218.5 ± 47  18.7 ± 58.7 
AB: Able-bodied; SCI: Spinal cord injury; E: Early transmitral velocity; A: Late 
transmitral velocity; E:A: Ratio of early to late transmitral velocity; DT: Deceleration 
time. 
Table 6 shows correlations between the changes in cardiac parasympathetic 
indices and the changes in diastolic parameters during the CFT. The able-bodied group 
showed significant correlations between changes in cardiac parasympathetic outflow and 
changes in early diastolic filling during the CFT.  In particular, the change in E was 
positively correlated with the change in SDNN (r=0.61; p=0.02) as well as the change in 
HFln (r=0.60; p=0.05). After adjusting for change in HR, there was a trend between the 
change in E and change in SDNN (r=0.54; p=0.09), while there was no correlation 
between the change in E and change in HFln (r=0.18; p=0.61). In addition, the able-
bodied participants showed a positive correlation between the change in E:A ratio and the 
change in CV (r=0.61; p=0.04), which was strengthened after adjusting for the change in 
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HR (r=0.72; p=0.04). Interestingly, the SCI group showed a trend for a negative 
correlation between the change in E and the change in HFln (r=-0.52; p=0.08). In 
addition, the SCI group also showed significant positive correlations between change in 
DT and change in HFln (r=0.7; p=0.01), as well as RMSSD (r=0.7; p=0.01), both of 
which showed strong correlations after adjusting for the change in HR (r=0.54; p=0.07 
for HFln and RMSSD).   
Table 6: Correlations between change in cardiac vagal activity and change in 
diastole during the CFT 
  AB SCI 
  E E 
HFln r=0.60; p=0.05* r=-0.52; p=0.08 
SDNN r=0.61; p=0.02* r=-0.10; p=0.97 
RMSSD r=0.46; p=0.14 r=-0.13; p=0.66 
CV r=0.30; p=0.37 r=0.01; p=0.97 
     
  A A 
HFln r=0.20; p=0.54 r=-0.53; p=0.06 
SDNN r=-0.02; p=0.95 r=-0.18; p=0.55 
RMSSD r=-0.03; p=0.92 r=-0.18; p=0.55 
CV r=-0.25; p=0.47 r=-0.26; p=0.40 
     
  E:A E:A 
HFln r=0.16; p=0.62 r=0.02; p=0.95 
SDNN r=0.43; p=0.16 r=0.11; p=0.73 
RMSSD r=0.42; p=0.17 r=-0.02; p=0.94 
CV r=0.61; p=0.04* r=0.22; p=0.47 
     
  DT DT 
HFln r=-0.19; p=0.56 r=0.67; p=0.01* 
SDNN r=-0.15; p=0.65 r=0.52; p=0.12 
RMSSD r=-0.09; p=0.77 r=0.68; p=0.01* 
CV r=0.01; p=0.97 r= 0.28; p=0.35 
*denotes significant correlation (p≤0.05)AB: Able-bodied; SCI: Spinal cord injury; : 
Change; E: Early transmitral velocity; HFln: natural log of the high frequency spectrum; 
SDNN: Standard deviation of continuous RR intervals; E:A: Ratio of early to late 
transmitral velocity; CV: Coefficient of variance; DT: Deceleration time RMSSD: Root 
mean square of differences between RR interval. 
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Discussion: 
 
 The main findings of the current investigation are that 1) able-bodied individuals 
who have greater parasympathetic outflow (as shown by HRV and QTVI) have greater 
early ventricular filling velocities, however this correlation is absent in individuals with 
SCI, 2) individuals with SCI demonstrate a blunted HR response to the CFT, despite 
strong trends towards increases in HRV and 3) cardiac vagal stimulation via the CFT is 
associated with improved LV filling in able-bodied individuals, yet reduced diastolic 
function in individuals with SCI. Together, these findings suggest an atypical disconnect 
between cardiac vagal outflow and both diastolic function and HR in individuals with 
SCI.   
Physiology of Cardiac Vagal-Diastolic Interaction: 
The isolated effect of parasympathetic activity on LV diastolic function is not 
very well understood. Part of the difficulty in discerning the isolated influence of 
autonomic activity on diastolic function is due to the concomitant effects of autonomic 
activity on HR, hemodynamic load and cardiac electrophysiology, all of which influence 
LV filling. Previous animal studies however suggest that vagal activity affects LV 
diastole, not by altering passive diastolic parameters (isovolumetric relaxation and/or LV 
compliance), but indirectly via left atrial function. For example, a previous study showed 
that direct vagal nerve stimulation in dogs increased LV filling as a result of an increase 
in left atrial pressure and left atrial-ventricular pressure gradient16. This is in agreement 
with work by Sarnoff et al., (1960), who also demonstrated an increase in left atrial 
pressure following direct vagus nerve stimulation in dogs30. In addition, vagal stimulation 
may also influence LV filling by reducing left atrial contractility, or late diastole. 
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Specifically, Williams et al. (1965) showed a 19% reduction in atrial contractility 
following direct vagus nerve stimulation in healthy dogs8. Conversely, studies in both 
animals and humans have shown that vagal withdrawal decreases early LV filling, partly 
by increasing atrial contractility7,10. Accordingly, vagal stimulation likely increases early 
diastolic filling by reducing left atrial contractility and increasing left atrial pressure10,16.   
Baseline Autonomic-Diastolic Interactions: 
 Regarding the first major finding of the study, at baseline, the able-bodied group 
demonstrated a positive correlation between early diastolic filling and cardiac 
parasympathetic activity, as shown by the QTVI and time and frequency measures of 
HRV. This is in agreement with results from Antelmi et al., (2010) who reported that 
healthy individuals with lower E:A ratios demonstrate lower HRV values15. Similarly, 
patients with diabetes who have lower HRV also demonstrate lower values of diastolic 
function12. This relationship however was not maintained in the present SCI group, as 
these individuals showed no correlations between early diastolic filling and cardiac 
parasympathetic activity. This suggests that there may be a disconnect between cardiac 
vagal activity and LV filling after SCI. Although it is unclear as to why the relationship 
between resting cardiac vagal activity and LV filling is lost in those with SCI, a possible 
explanation could be reduced baroreceptor sensitivity. Baroreceptor function was not 
assessed in the current study, however it has been shown to be reduced in individuals 
with SCI31,32. Baroreceptors in the left atrium modulate cardiac autonomic activity 
according to atrial pressure (which is dependent on left atrial volume). An increase in 
atrial pressure decreases sympathetic outflow and increases parasympathetic activity33. 
Accordingly, this increase in parasympathetic activity could augment diastolic filling8,16. 
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Therefore, if the current SCI participants had impaired baroreceptor sensitivity, this may 
be responsible for the observed disconnect between cardiac parasympathetic activity and 
ventricular filling, however, further research is warranted in order to investigate the 
relationship between baroreceptor function and diastolic function in individuals with SCI.   
Autonomic & Diastolic Responses to the CFT: 
The CFT was used in this study as a non-invasive analogue for cardiac vagal 
stimulation20,21. Normally, facial surface nociceptors are stimulated when subjected to a 
cold stimulus, and this activates the maxillary and opthalamic branches of the trigeminal 
nerves which are mainly sensory in function. Afferent nociceptor signals from the 
trigeminal nerve increase vagal efferent signals, which result in pronounced 
bradycardia34. Regarding the second major finding of the study, the able-bodied group 
demonstrated the typical physiological response to the CFT, which included an elevation 
in cardiac parasympathetic activity, as shown by elevation in HRV, and a significant 
reduction in HR. This has been repeatedly shown before in healthy humans suggesting 
intact cardiac vagal function20,21,35. In addition, since breath holding or changing 
breathing rate during the CFT can augment the resultant bradycardia36,37, participants in 
the current study were continuously instructed to maintain their normal breathing rate 
during the test. Therefore, the observed changes in HRV and HR were likely due to 
alterations in vagal activity and not changes in breathing. In contrast, the SCI group 
exhibited a strong trend towards an increase in cardiac vagal activity (increased HRV), 
however, they did not show changes in HR during the CFT. It is important to note the 
effect sizes for HRV parameters were quite large, suggesting that the SCI did exhibit an 
increase in HRV, but statistical significance was not reached due to the relatively small 
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sample size. Blunted or reduced bradycardic response to facial cooling has been 
previously documented in older individuals38,39, suggesting that individuals with SCI may 
exhibit accelerated cardiovascular aging. Although such accelerated cardiovascular aging 
has been suggested to be partly due to the profound physical inactivity following SCI19,40, 
this is likely not the case here, as the majority of the participants in this study participated 
in mild weekly exercise and used manual wheelchairs for transportation. The only other 
study to employ the CFT in individuals with SCI reported no changes in cardiac vagal 
activity and an unexpected tachycardia19. This inconsistency in results is interesting 
especially that the participants involved in the study by Wecht et al (2009) were similar to 
our participants with respect to age, years post injury and level of injury. A possible 
explanation for the difference in results could be from the difference in facial cooling 
temperatures used in the studies. Wecht et al. (2009) performed the CFT at a temperature 
of 4◦C, whereas we did it at a temperature of 1◦C. Heath et al (1990) showed that colder 
temperatures during the CFT elicit greater parasympathetic responses than warmer 
temperatures41, and therefore face cooling at a temperature of 4C may have not been 
sufficient enough to elicit a vagal response, or an increase in HRV in those with SCI. 
However, regardless of a blunted19 or augmented vagal response (current study) to the 
CFT, individuals with SCI still show atypical HR activity to the CFT. Such paradoxical 
HR responses to facial cooling has been hypothesized to be due to possible alterations in 
cardiac cholinergic receptors19, however, further investigations are warranted. In addition, 
potential impairments to baroreceptor sensitivity likely did not contribute to the blunted 
HR response in the SCI group, as the CFT has been shown to operate independently from 
baroreceptor function20,21.  
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Regarding the third major finding of the study, the CFT was also used to increase 
vagal stimulation in order to further understand diastolic-autonomic dynamics. During the 
CFT, the able-bodied group showed positive correlations between increases in HRV and 
diastolic filling (E and E:A ratio). This relationship was maintained after controlling for 
changes in HR, suggesting that the increased ventricular filling was not entirely driven by 
the change in HR, but by parasympathetic activity. Although atrial pressure was not 
measured in the current study, we speculate that an increase in atrial pressure may have 
resulted in the augmented early diastolic filling in the able-bodied individuals16,30. This 
diastolic response to elevated cardiac vagal activity has been previously demonstrated in 
experimental models8,16, suggesting that the able-bodied group displayed normal 
autonomic-diastolic interactions.  Interestingly enough, the SCI group displayed an 
atypical diastolic response to the increased HRV during the CFT. Specifically, there was 
a trend for a negative association between the change in E and the change in HFln during 
the CFT. In addition, the increase in HRV was strongly associated with prolongation of 
DT in individuals with SCI. These correlations suggest that unlike the able-bodied group, 
the SCI group exhibit a paradoxical reduction in left ventricular filling efficiency in 
response to elevated cardiac parasympathetic activity. This does not necessarily mean 
that vagal activity is detrimental to cardiac function after SCI, but it may be pointing at an 
underappreciated alteration in autonomic modulation of cardiac function, which requires 
further investigation.   
As such, this data presents novel evidence for atypical HR and diastolic responses 
to cardiac vagal activity and a potential disconnect between autonomic and cardiac 
function in individuals with SCI. It is difficult to discern the source or mechanisms 
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behind such physiological alterations from the methods used in the current study. This is 
because ECG-based assessments of cardiac autonomic function are a downstream 
measure that reflects the collective actions of supraspinal activity, vagus nerve outflow, 
cholinergic receptor uptake of acetylcholine, and electric conduction throughout the 
heart. As such, the impairments that led to the observed autonomic-cardiac disconnect in 
the SCI group can be attributed to one or more of any of these steps. Therefore, further 
studies are warranted in order to elucidate the source of physiological dysfunction.  
Conclusion: 
 Resting cardiac vagal outflow is associated with early LV filling in able-bodied 
individuals, however this relationship is lost in those with SCI. In addition, increasing 
cardiac vagal outflow via the CFT is associated with increasing early diastolic filling in 
able-bodied individuals, but is associated with impaired LV diastole in those with SCI. 
Furthermore, individuals with SCI demonstrate a blunted HR response to increased 
cardiac vagal activity during the CFT.       
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Abstract:  
 
Background: There remains a lack of consensus on alterations in diastolic function 
following spinal cord injury (SCI). Hypovolemia following paralysis may play a role in the 
putative diastolic impairments, however, diastolic function has only been examined during 
resting conditions in those with SCI.  
Objectives: 1) To examine diastolic function at rest and during rapid saline infusion in 
those with SCI and 2) to determine the contribution of blood volume to the purported 
diastolic impairments in SCI.  
Methods: Thirteen SCI (Age: 41±8.5; 10 males, 3 females) and 12 able-boded (AB) 
individuals (Age: 40±8.5; 9males, 3 females) without history of cardiovascular disease 
participated in the study. M-Mode and 2-dimensional echocardiography were used to 
assess left ventricular structure as well as pulse-wave Doppler and tissue Doppler indices 
of diastole. The carbon monoxide rebreathe test was employed to measure blood volume. 
Rapid saline infusion was performed to increase preload (Dose:15mL/Kg; 
rate:100mL/min) and diastolic function was assessed once more after volume loading.  
Results: Individuals with SCI had smaller LV internal diameter (SCI: 4.5±0.3 cm vs AB: 
5.1±0.7cm; p=0.01) and lower preload, as evidenced by lower blood volume (SCI: 
3.9L±0.6L vs AB: 5.0±1.2L; p=0.02) and end diastolic volume (SCI: 97.2±29.4ml vs AB: 
128.6±38.3ml; p=0.03). There were no differences in any of the baseline diastolic 
velocity parameters between groups, however when LV internal diameter was adjusted 
for, individuals with SCI demonstrated lower early to late transmitral velocity ratio (SCI: 
1.9±0.5 vs AB: 2.2±0.7; p=0.03). There were no between-group differences in diastolic 
responses to the saline infusion, as both groups showed similar degrees of diastolic 
velocity augmentations following volume loading.  
Conclusion: Individuals with SCI have preserved diastolic function despite having lower 
preload. Cardiac atrophy in SCI may serve as a positive adaptation that maintains normal 
diastolic velocities. Individuals with SCI also demonstrate similar diastolic responses to 
increased preload in comparison to an able-bodied control group, suggesting compliant 
ventricles.  
 
Key Words: Spinal cord injury, diastolic function, saline infusion, blood volume, 
preload 
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Introduction: 
 
 Individuals with spinal cord injury (SCI) represent one of the most physically 
inactive populations, due to their profound immobility. Accordingly, such immobility 
results in an elevated risk of a wide array of cardiovascular complications, including 
coronary artery disease1, peripheral artery disease2, atherosclerosis3 and accelerated 
cardiovascular aging4. Although severe physical inactivity has been shown to be 
associated with impaired diastolic function in able-bodied individuals5-7, findings 
regarding diastolic function after SCI remain equivocal. Left ventricular diastolic 
function has been shown by some to be preserved in those with SCI8-10 while more recent 
reports convey diastolic impairments after SCI11-14. Therefore, it is unknown if diastolic 
dysfunction actually manifests after spinal cord injury.   
It is important to note that echocardiographic parameters of diastolic function are 
highly influenced by preload. Specifically, an increase in preload augments diastolic 
values while a decrease in preload reduces them15-18. Individuals with SCI demonstrate 
reduced ventricular filling and preload, partly due to a reduction in blood volume 
secondary to chronic physical inactivity19. Therefore, it is not clear if the reported 
diastolic impairments following SCI are a result of reduced blood volume or due to 
pathological alterations in the left ventricle, per se. In addition, diastolic function in 
individuals with SCI have previously only been examined while participants were in a 
relaxed state, and therefore it is unclear how ventricular filling after SCI functions when 
the heart is exposed to stress. Rapid saline infusion is a diagnostic method that increases 
preload, and may reveal left ventricular impairments that may otherwise not manifest 
during resting conditions20. In addition, the normal diastolic responses to rapid saline 
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infusion are well documented17,18, and therefore this method maybe a useful tool to 
elucidate any potential left ventricular diastolic impairments in individuals with SCI.  
Accordingly, the purpose of this study was to determine if individuals with SCI 
demonstrate diastolic impairments at rest and/or during a volume stress induced by rapid 
saline infusion. We also aimed to determine if a reduction in blood volume following SCI 
contributes to the putative diastolic impairments in this population.  
 
Methods: 
 
Participants: 
 Thirteen individuals with spinal cord injury (C4-T5; 7 complete, 6 incomplete; 
16.5±9.7 years post injury) and 12 able-bodied individuals matched for age, sex and body 
mass participated in this study. Participants were non-smokers, non-hypertensive, did not 
have a history of heart disease and had normal resting and exercise electrocardiograms. 
As this is the first study to perform rapid saline infusion in individuals with SCI, those 
with unstable autonomic dysreflexia were excluded. Participants from both groups 
included a range of sedentary to physically active individuals but none were competitive 
or highly trained athletes. All participants provided informed consent to participate in the 
study, which was approved by the Brock University Biosciences Research Ethics Board.  
General Study Protocol: 
 All participants were required to void their bladder before testing, especially those 
with SCI in order to reduce any risk of autonomic dysreflexia. Body mass (kg) and height 
were measured and from this body mass index (BMI: kg/m2) was calculated. After a 15-
minute resting period in the left lateral decubitus position, resting blood pressure was 
obtained manually from the brachial artery and a continuous electrocardiogram recording 
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(lead II) was taken throughout the testing session. Following the rest period, assessment 
of left ventricular structure and function was performed via 2-Dimensional and M-mode 
echocardiography. Participants then performed the carbon monoxide rebreathe test for the 
measurement of total blood volume. This was then followed by rapid saline infusion. 
After 5 minutes of saline infusion, left ventricular diastolic function was assessed once 
more. 
Echocardiography: 
All echocardiographic images were obtained using a commercially available 
ultrasound system (Vivid Q; GE Vingmed Ultrasound AS, Horten, Norway) with a 1.5-
MHz phased-array transducer. All images were acquired by a single experienced 
sonographer and were stored for later offline analysis using commercially available 
software (EchoPac version 6.0; GE Vingmed Ultrasound AS). Images were obtained 
while participants were in the left lateral decubitus position at end expiration and 3 
consecutive cycles for each image were stored and averaged for offline analysis.   
 Left ventricular wall dimensions were assessed at end diastole and end systole via 
M-mode recordings (and values were confirmed by 2-dimensional recordings) in 
accordance the recommendations of the American Society of Echocardiography (ASE) 
(21). Left ventricular wall dimensions included intraventricular septal thickness at 
diastole (IVSd) and systole (IVSs), posterior left ventricular internal diameter at diastole 
(LVIDd) and systole (LVIDs) as well as posterior wall thickness in diastole (PWTd) and 
systole (PWTs). Hemodynamic measures included end-diastolic volume, end-systolic 
volume, ejection fraction, as well as stroke volume. These measures were taken from the 
long parasternal axis view through M-mode, as apical chamber views from individuals 
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with SCI are suboptimal for the use of Simpson’s Biplane. Cardiac output was calculated 
as the product of stroke volume and heart rate. Left ventricular mass (LVM) was 
calculated using the Devereux formula22 and was indexed for body surface area 
(LVMi)23.  
 Pulsed-wave Doppler and tissue Doppler were employed to assess diastolic 
function according to the recommendation of the American Society of 
Echocardiography24. For mitral inflow velocity, from an apical 4-chamber view, a 4mm 
sample volume was placed between the mitral valve leaflet tips during diastole. The 
Doppler velocity curves were digitized to obtain peak early (E) and late (A) mitral flow 
velocities, and their ratio (E:A) was calculated. The descending limb of the E wave was 
used to measure deceleration time (DT) and isovolumetric relaxation time (IVRT) was 
measured as the time between aortic valve closure and mitral valve opening. Mitral 
annular velocities were measured via tissue-Doppler imaging from the 4-chamber apical 
view. A 2mm sample volume was placed along the longitudinal movement of the basal 
septal and basal lateral walls. Peak early (E’) and late (A’) diastolic myocardial tissue 
velocities were recorded and E:E’ was calculated as a non-invasive measure of left 
ventricular filling pressure25. 
Carbon-Monoxide Rebreathe Test: 
 The carbon-monoxide rebreathe test was employed for the assessment of total 
blood volume in accordance to the Burge and Skinner method26. Briefly, a 20-gauge 
catheter was placed in the antecubital vein for instant blood draws. A baseline blood 
sample was taken for measurement of hematocrit. After a 4-minute period of breathing 
100% oxygen (Praxair), participants inhaled a 15-20ml priming dose of 100% CO gas 
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(Praxair) and a 1mL blood sample was obtained in a heparinized vacutainer for 
assessment of carboxy-hemoglobin and total-hemoglobin. A second dose of carbon-
monoxide gas (40-50ml) was inhaled, and after 10 minutes of breathing, a final blood 
sample was obtained for carboxy-hemoglobin assessment. All blood samples were 
analyzed by a blood-gas analyzer via photospectromery (Phox-Cooximeter; 
NovaBiomedical). The carbon-monoxide rebreathe test yields a low reproducibility error 
in both able-bodied27 and SCI individuals19 and total blood volume was reported in 
absolute values and indexed for body mass.  
Volume Loading: 
 Preload was increased via rapid infusion of warm isotonic saline (0.9% NaCl) 
through the antecubital vein by a 18-20 gauge catheter. The saline dose consisted of 
15mL/kg at a rate of 100mL/min.  
Statistical Analysis: 
 A Shapiro’s Wilkis test was used to check for normalcy in all parameters, and as a 
result, parametric statistics were justified. Unpaired t-tests were used to compare all 
baseline left ventricular structural, diastolic and hemodynamic parameters between groups. 
An analysis of covariance (ANCOVA) was used to assess differences in baseline diastolic 
parameters while adjusting for LVIDd. The LVIDd was used as a covariate because a 
reduction in left ventricular size following SCI has been proposed as a mechanism to 
maintain normal diastolic function despite a reduction in preload8,28 and LVIDd had an 
equal regression coefficient associated with both groups (assumption of homogeneity of 
regression). A 2-way repeated measures analysis of variance (ANOVA) was used to detect 
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group by condition (IV infusion) interactions as well as main effects for diastolic 
parameters. Statistical analyses were performed using  Statistical Package for Social 
Sciences (SPSS 22) software. Data were reported as means ± standard deviation, and level 
of statistical significance was set at p≤0.05.  
Results: 
 
Participants: 
 All participant characteristics are provided in Table 1. There were no between 
group differences in age, body mass, BMI or heart rate (p>0.05). All participants tolerated 
the rapid saline infusion well and no adverse events occurred.   
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Table 1: Participant characteristics 
Participant 
Age 
(years) Sex 
Body 
Mass(kg) BMI(kg/m2) HR(bpm) Level AIS YPI 
SCI         
1 55 M 80.7 26.8 73 C4 A 8 
2 42 M 68.2 20.8 53 C4 C 18 
3 31 F 64.0 22.7 61 C5 B 6 
4 46 M 83.0 28.7 65 T6 A 19 
5 23 M 83.2 27.8 57 C8 B 5 
6 43 M 81.0 27.1 43 C4 A 6 
7 46 F 61.0 22.7 73 C7 A 9 
8 37 M 100.0 31.6 70 C5 B 18 
9 38 M 96.4 25.9 54 C5 C 38 
10 54 M 95.0 29.3 55 C567 D 27 
11 38 F 56.0 21.1 64 T3 A 20 
12 41 M 66.0 24.2 77 T5 A 16 
13 44 M 91.0 27.2 67 T4 A 24 
AVE 41.4  78.9 25.8 62 --- --- 16.5 
SD 8.6  14.6 3.3 9 --- --- 9.7 
AB         
1 44 M 94.3 26.3 50 --- --- --- 
2 44 M 70.1 24.8 47 --- --- --- 
3 35 F 57.2 21.2 75 --- --- --- 
4 35 M 76.0 24.5 62 --- --- --- 
5 41 M 102.0 30.5 51 --- --- --- 
6 44 F 68.3 24.9 43 --- --- --- 
7 30 F 57.4 20.9 63 --- --- --- 
8 33 M 91.1 27.8 51 --- --- --- 
9 54 M 102.1 27.4 62 --- --- --- 
10 51 M 97.1 28.9 54 --- --- --- 
11 46 M 80.3 24.6 71 --- --- --- 
12 24 M 80.0 26.1 60 --- --- --- 
AVE 40.1  81.2 25.7 57 --- --- --- 
SD 8  16.2 2.8 9 --- --- --- 
p-value 0.71 --- 0.71 0.90 0.22 --- --- --- 
AB: Able-bodied; AIS: ASIA impairment scale where ASIA stands for American Spinal 
BMI: Body mass index; Injury Association; HR: Heart rate; SCI: Spinal cord injury; YPI: 
Years post injury  
 
 
122 
 
 
 
Baseline Left Ventricular Structure and Hemodynamics: 
 Compared to able-bodied participants, individuals with spinal cord injury had 
significantly smaller LVIDd, and lower end diastolic volume, stroke volume and cardiac 
output, however ejection fraction was not different between groups (Table 2). There were 
no between-group differences in LVM, LVMi or any of the other structural parameters. 
Absolute total blood volume and blood volume indexed for body mass were significantly 
lower in the spinal cord injury group (Table 2). In addition, there were no between-group 
differences in any of the diastolic parameters (Table 3), however after controlling for 
LVIDd, the spinal cord injury group demonstrated a significantly lower E:A ratio (Table 
3).    
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Table 2: Baseline LV structural and hemodynamic parameters 
  AB SCI P-value  
IVSd(cm) 1.0 ± 0.2 1.1 ± 0.3 0.30 
LVIDd(cm) 5.1 ± 0.7* 4.5 ± 0.5 0.01 
LVPWd(cm) 1.1 ± 0.3 1.0 ± 0.2 0.61 
IVSs(cm) 1.7 ± 0.7 1.4 ± 0.4 0.20 
LVIDs(cm) 3.2 ± 0.3 2.9 ± 0.5 0.22 
LVPWs(cm) 1.7 ± 0.5 1.5 ± 0.3 0.17 
LVM(g) 201.9 ± 94 164.4 ± 51.6 0.24 
LVMi(g/m2) 104.6 ± 46.1 87.3 ± 23.0 0.24 
EDV(ml) 128.6 ± 38.3* 97.2 ± 29.4 0.03 
ESV(ml) 39.2 ± 11.6 32.75 ± 12.2 0.31 
EF(%) 68.7 ± 6.2 64.5 ± 6.1 0.10 
SV(ml) 88.8 ± 31* 61.9 ± 18.2 0.01 
CO (L/min) 4.9 ± 1.6* 3.6 ± 0.89 0.02 
Blood Volume (L) 5.0 ± 1.2* 3.9 ± 0.6 0.02 
Blood Volume (mL/Kg) 65.4 ± 10.5* 52.7 ± 11.4 0.01 
* denotes significantly different from SCI group (p<0.05); AB: Able-bodied; SCI: spinal 
cord injury; IVSd: Intraventricular septal wall thickness in diastole; LVIDd: Left 
ventricular internal diameter in diastole; LVPWd: Left ventricular posterior wall in 
diastole; IVSs: Intraventricular septal wall thickness in systole; LVIDs: Left ventricular 
internal diameter in systole; LVPWs: Left ventricular posterior wall thickness in systole; 
LVM: Left ventricular mass; LVMi: Left ventricular mass indexed for body surface area; 
EDV: End diastolic volume; ESV: End systolic volume; EF: Ejection fraction; SV: 
Stroke volume; CO: Cardiac output.  
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Table 3: Baseline diastolic function before and after controlling for LV structure  
  AB SCI P-Value 
P-Value (with 
LVIDd as a 
covariate) 
E (m/sec) 0.77 ± 0.12 0.76 ± 0.11 0.39 0.64 
A (m/sec) 0.38 ± 0.11 0.42 ± 0.08 0.26 0.09 
E:A 2.16 ± 0.72* 1.9 ± 0.51 0.14 0.03 
DT (ms) 197.8 ± 61.0 210.7 ± 48.4 0.81 0.92 
IVRT (ms) 103.6 ± 18.4 102.8 ± 18.8 0.82 0.43 
E'Sept 0.12 ± 0.03 0.13 ± 0.02 0.84 0.70 
E'Lat 0.14 ± 0.03 0.16 ± 0.04 0.22 0.30 
A'Sept 0.08 ± 0.02 0.10 ± 0.03 0.19 0.11 
A'Lat 0.08 ± 0.03 0.08 ± 0.03  0.79 0.33 
EE' 6.1 ± 1.4  5.4 ± 1.07 0.10 0.96 
* denotes significantly different from SCI group after controlling for LVIDd (p<0.05); 
AB: Able-bodied; SCI: Spinal cord injury; E: Early transmitral diastolic velocity; A: Late 
transmitral diastolic velocity; E:A: Early to late diastolic velocity ratio; DT: Deceleration 
time; IVRT: Isovolumetric relaxation time; E’Sept; Early septal annular myocardial 
diastolic velocity; E’Lat: Early lateral annular diastolic velocity; A’Sept: Late septal 
annular myocardial diastolic velocity; A’Lat: Late lateral myocardial diastolic velocity; 
EE’: Ventricular filling pressure.  
 
Diastolic Response to Rapid Saline Infusion:  
 There was no difference in the average amount of saline given to both groups 
(SCI:1184±214mL vs able-bodied: 1208±252mL; p=0.80). There were no group by 
condition interactions for any of the diastolic measures (p>0.05), suggesting that both 
groups responded similarly to the rapid saline infusion. However, there was a significant 
main effect for condition, specifically when collapsing across groups, the saline infusion 
resulted in a significant increase in E (0.78 ± 0.10m/sec to 0.90 ± 0.11m/sec; p<0.01; Figure 
1a) and the E:A ratio (2.06 ± 0.61 to 2.82 ± 1.05; p<001; Figure 1b), as well as a significant 
decrease in A (0.40 ± 0.09m/sec to 0.35 ± 0.11m/sec; p=0.05; Figure 1c), DT (208.37 ± 
50.04ms to 183.16 ± 37.21ms; p=0.01; Figure 1d) and IVRT (102.04 ± 17.54ms to 88.42 
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± 14.11ms; p<0.01; Figure 1e). The saline infusion also resulted in a significant increase 
in E’Sept (0.13 ± 0.02m/sec to 0.14 ± 0.03 m/sec; p=0.01) and E’Lat (0.15 ± 0.04m/sec to 
0.17 ± 0.04m/sec; p<0.001) velocities. Rapid saline infusion resulted in no changes in 
A’Sept velocity (0.09 ± 0.02m/sec to 0.10 ± 0.03; p=0.20), A’Lat velocity (0.08 ± 
0.03m/sec to 0.08 ± 0.03m/sec; p=0.40) or left ventricular filling pressure as indicated by 
E:E’ (5.8 ± 1.3 to 6.0 ± 1.2; p=0.40). In addition, Table 4 shows that the percent change in 
diastolic values in response to the saline infusion was similar between groups.  
               Table 4: Percent change in diastolic function after rapid saline infusion 
  AB SCI P-Value 
E 14.1 ± 21.0 19.9 ± 15.9 0.43 
A -4.8 ± 33.2 -12.9 ± 33.2 0.49 
EA 32.3 ± 47.6 47.1 ± 42.2 0.42 
DT -7.5 ± 21.8 -11.7 ± 17.3 0.6 
IVRT -11.8 ± 20.6 -13.8 ± 13.1 0.78 
E'Sept 13.9 ± 18.5 13.5 ± 26.0 0.96 
E'Lat 17.5 ± 20.5 7.9 ± 16.4 0.22 
A'Sept 13.1 ± 22.7 2.3 ± 19.8 0.22 
A'Lat 2.4 ± 16.6 -10.7 ± 19.2 0.09 
EE' 1.4 ± 24.3 0.3 ± 17.1 0.28 
AB: able-bodied; SCI: spinal cord injury; E: early transmitral diastolic velocity; 
A: late transmitral diastolic velocity; E:A: early to late diastolic velocity ratio; 
DT: deceleration time; IVRT: isovolumetric relaxation time; E’Sept; early septal 
annular myocardial diastolic velocity; E’Lat: early lateral annular diastolic 
velocity; A’Sept: late septal annular myocardial diastolic velocity; A’Lat: late 
lateral myocardial diastolic velocity; EE’: ventricular filling pressure. 
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Figure 1a: Early transmitral diastolic velocity after rapid saline infusion.  
* denotes significant main effect for condition (p<0.05); E: Early transmitral diastolic 
velocity AB: able-bodied; SCI: Spinal cord injury. 
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Figure 1b: Ratio of early to late transmitral filling velocity after rapid saline 
infusion
 
* denotes significant main effect for condition (p<0.05); E:A: Early to late diastolic 
velocity ratio; AB: Able-bodied; SCI: Spinal cord injury. 
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Figure 1c: Late transmitral diastolic velocity after rapid saline infusion. 
* 
denotes significant main effect for condition (p<0.05); A: Late transmitral diastolic 
velocity; AB: Able-bodied; SCI: Spinal cord injury.  
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Figure 1d: Transmitral deceleration time after rapid saline infusion. 
  
* denotes significant main effect for condition (p<0.05); DT: deceleration time; AB: 
Able-bodied; SCI: Spinal cord injury.  
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Figure 1e: Isovolumetric relaxation time after rapid saline infusion. 
 
* denotes significant main effect for condition (p<0.05); IVRT: isovolumentric relaxation 
time; AB: able-bodied; SCI: spinal cord injury.  
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Discussion: 
 
 The main findings of this investigation were that 1) individuals with SCI have 
preserved left ventricular diastolic function at rest despite having a lower blood volume, 2) 
cardiac atrophy following SCI may play a role in preserving diastolic function in response 
to lower preload and 3) rapid saline infusion resulted in similar left ventricular filling 
patterns between SCI and able-bodied individuals. 
Baseline Diastolic Function  
The current investigation showed that individuals with SCI have preserved left 
ventricular diastolic function at rest. This has been corroborated by previous studies where 
normal diastolic function was reported in individuals with complete tetraplegia8 and 
paraplegia10 regardless of being sedentary9 or active28. However, other investigators have 
reported reduced diastolic function following SCI11-14. It has been proposed that the chronic 
physical inactivity after SCI may play a role in such diastolic impairments, as active SCI 
individuals have been shown to present better diastolic patterns compared to sedentary 
ones11,14. However, Maggioni et al., (2002) reported no difference in diastolic function 
between trained and untrained SCI individuals29 and De Groot et al., (2006) also reported 
no difference between able-bodied individuals and sedentary individuals with severe 
tetraplegia8. In addition, Driussi et al., (2014) reported lower diastolic function in those 
with SCI compared to able-bodied individuals even after controlling for levels of physical 
activity, suggesting physical activity did not play a major role in the diastolic 
impairments12. It is interesting to note however, that in two of the studies that reported 
diastolic impairments after SCI12,13, the SCI groups exhibited left ventricular concentric 
hypertrophy, which is a pattern often seen in individuals with diastolic heart failure30. 
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Therefore, these individuals may have had other concomitant disorders that resulted in 
unfavorable left ventricular structural alterations which in turn caused diastolic 
impairments. 
Diastolic Function after Saline Infusion 
To our knowledge, this is the first study to perform rapid saline infusion in 
individuals with SCI. Rapid saline infusion is an excellent diagnostic method for 
unmasking cardiac dysfunctions that otherwise may not manifest during resting 
conditions20. If a ventricle is compliant, then diastolic function should be augmented in 
response to increased loading without significant changes in left ventricular filling 
pressures17,18. In contrast, a non-compliant ventricle will demonstrate significant elevations 
in filling pressure after increased volume loading20. Both groups in the current investigation 
demonstrated similar changes in all diastolic parameters and both groups showed no 
changes in left ventricular filling pressures, as shown by E:E’. This is evidence that the left 
ventricle of the current SCI cohort is compliant and does not appear to have intrinsic 
pathological alterations. In addition, both groups received the same average dose of saline 
despite the SCI group having a smaller left ventricle. This means that the left ventricle in 
those with SCI likely expanded relatively more during the infusion with no significant 
changes in filling pressure, which further supports the notion that left ventricular elasticity 
is maintained after SCI.  
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Positive Morphological Adaptation: 
Due to the lower blood volume and preload (end diastolic volume) demonstrated 
by the SCI group, a reduction in left ventricular diastolic function was expected. However, 
both groups showed similar values for all diastolic parameters. This was unexpected, since 
hypovolemia has been shown to reduce ventricular diastolic function5,15 and compliance7. 
However, despite the SCI participants being hypovolemic with lower preload, diastolic 
function was still preserved. This may be mediated by the smaller ventricular chamber size, 
as shown by a smaller LVIDd, which is likely a morphological adaptation to the chronic 
reduction in preload. A smaller chamber size may preserve diastolic velocities despite a 
lower preload by maintaining ventricular wall stress. Although this has been hypothesized 
to occur after SCI8,28, this is the first study to show evidence of such a mechanism, as the 
SCI group demonstrated reduced diastolic function (lower E:A ratio) only when controlling 
for LVID. In addition to reduced preload, SCI is associated with severe skeletal muscle 
atrophy32, peripheral vasculature atrophy33 and a decrease in capillary density34 all of which 
play a role in reduced overall oxygen supply and demand33,35. As a result, the heart is not 
required to maintain a normal size and therefore, it likely atrophies in accordance to the 
systemic muscular and vascular atrophy after paralysis. Therefore, the cardiac atrophy that 
occurs after SCI may be a positive morphological adaptation which preserves normal 
cardiac function and allows the heart to operate in accordance to lower systemic demands. 
Structural and Hemodynamic Findings: 
Although stroke volume and cardiac output were lower in the SCI group, this was 
likely due to the reduced preload and not due impaired ventricular contractility, as 
evidenced by similar ejection fractions between groups. Furthermore, the observed 
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reduction in LVIDd demonstrated by the SCI participants is in agreement with several 
previous reports10-12,28. However, the commonly reported reduction in LVM in this 
population8-10,28,29 was not observed in the current participants. As mentioned, the smaller 
LVIDd can be explained by the chronic reduction in preload, as demonstrated by a lower 
end diastolic volume and blood volume. The reduction in preload decreases ventricular 
mass to volume ratio, thus decreasing ventricular wall stress and consequently resulting in 
adaptive cardiac atrophy36. In addition, the left ventricle is highly adaptive to changes in 
loading conditions, as cardiac atrophy has been shown to occur in as little as 2 weeks of 
reduced preload36.  
The blood volume values obtained in our study are comparable to those reported 
by Houtman et al. (2000), whose participants had a similar distribution of injury levels 
compared to the current study (C4-T6)19. Physical inactivity is a known stimulus for 
hypovolemia6,7,37, thus the smaller blood volume in SCI individuals is likely due to their 
low physical activity levels. However, it is interesting to note that the reduction in blood 
volume in response to physical inactivity is typically demonstrated from models of severe 
immobilization, such as bed rest31,37 and spaceflight. The SCI individuals in the current 
study were not completely immobilized, as they used manual wheelchairs for their main 
method of transportation, they performed daily transfers and the majority of them 
participated in regular aerobic and resistance exercise with the upper limbs. However, 
although being relatively active, they still demonstrated a lower blood volume compared 
to the able-bodied group. This suggests that moderate upper limb activity is insufficient to 
maintain blood volume after SCI and perhaps lower limb exercise is required in this regard.  
This hypothesis is supported by an exercise study that reported no change in blood volume 
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following 6 weeks of arm ergometry in individuals with SCI despite an increase in exercise 
performance38. In contrast, Houtman et al., (2000) demonstrated significant elevations in 
blood volume in individuals with SCI following only 2 weeks of electrically stimulated leg 
cycling exercise19.  
Limitations: 
 The primary limitation to this study was the small number of participants given the 
difficulty of recruiting a large number of individuals with SCI. Another limitation is that 
we based our conclusions from non-invasive measures, thus further studies employing 
more direct measures of ventricular structure and function are warranted. Finally, all 
individuals with SCI were grouped together due to the small sample size; therefore, larger 
studies are required to compare diastolic function between different severities and levels 
of injury.    
Conclusion: 
 Although individuals with SCI have lower blood volume, which results in reduced 
preload, diastolic function was still preserved at rest. The cardiac atrophy that occurs after 
SCI may play a role in maintaining normal diastolic function. In addition, individuals with 
SCI demonstrated normal ventricular filling responses to rapid saline infusion, suggesting 
that the left ventricle is compliant in these individuals.  
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Chapter 8 – General Discussion  
 
The cardiovascular system is comprised of the heart and blood vessels, both of 
which function independently but are also highly dependent on each other. In addition, 
both of these components of the cardiovascular system are under constant modulation of 
higher commands from the nervous system. As such, this tight-knit relationship between 
the heart, blood vessels and autonomic nervous system is required for the execution of 
appropriate cardiovascular function. However, at the same time, it is this close link 
between the different components of the cardiovascular system that makes it an 
interesting but difficult system to study. The majority of cardiovascular disorders rarely 
manifest in isolation, rather they are usually the result of a concomitant co-morbidity or 
lead to the genesis of different cardiovascular pathologies. For example, left ventricular 
diastolic dysfunction is a disease mainly characterised by impaired ventricular relaxation. 
However, it typically manifests as a result of hypertension, which is mainly a disorder of 
stiff blood vessels. Stiffer blood vessels also increase the risk of atherosclerosis which, if 
not treated, can lead to an embolism that can result in a myocardial infarction. 
Myocardial infarction can further exacerbate the initial diastolic dysfunction, leading to 
overt heart failure and autonomic neuropathies, which in turn can cause further vessel and 
cardiac impairments. It is therefore imperative to study more than one aspect of the 
cardiovascular system in populations that may be at an elevated risk for cardiovascular 
dysfunctions in order to delineate the origin and progression of the pathology, and to 
improve interventions for prevention and treatment.   
The autonomic nervous system plays a critical role in the regulation of 
cardiovascular function in both healthy and diseased states. For example, in a healthy 
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state, the balance between parasympathetic and sympathetic activity ensures that the 
cardiovascular system is relaxed during rest and is sufficiently excited when there is a 
stressor. Conversely, in conditions associated with autonomic impairments, this balance 
between the parasympathetic and sympathetic systems can be offset which may lead to 
abnormal over/under activity of one or both autonomic limbs1. Furthermore, the 
autonomic state of an individual can have diagnostic and prognostic value and can 
provide information regarding the relative risk of cardiovascular-related mortality and 
morbidity. Given the importance of autonomic function to cardiovascular health, it is 
critical for clinicians and researchers to use valid and reproducible tools of autonomic 
assessment. Not only must these tools be valid and reproducible, but they must also be 
practical, since methods such as direct sympathetic and vagus nerve activity 
measurements may not always be feasible.  
Left ventricular diastolic function has traditionally not received as much attention 
as its systolic counterpart. This is in part, because ventricular function has been 
conventionally evaluated by the heart’s ability to eject blood via measures such as 
ejection fraction, stroke volume or cardiac output. However more recent evidence 
suggests that diastolic dysfunction may actually precede systolic dysfunction2 and may 
even be partly responsible for the genesis of heart failure3. In addition, isolated diastolic 
dysfunction can occur in the absence of systolic dysfunction and may be falsely attributed 
to impaired systolic function as it too can present reduced cardiac output and stroke 
volume. Accordingly, it is imperative to investigate the mechanisms behind diastolic 
dysfunction in clinical populations in order to develop appropriate preventative 
interventions from further cardiovascular degradation.    
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The array of cardiovascular dysfunctions associated with spinal cord injury (SCI) 
are well established4. In fact, cardiovascular disease is the leading cause of mortality in 
the SCI population5. Reduced cardiac autonomic regulation after SCI may play a 
significant role in this elevated risk, as individuals with SCI have been reported to display 
reduced cardiac vagal activity6, accelerated cardiac autonomic aging7, and depending on 
the injury level they can either have reduced8 or elevated cardiac sympathetic activity9. 
As such, valid and reliable tools for assessing cardiac autonomic function are greatly 
needed in order to measure the autonomic state of individuals following their injury, and 
to monitor autonomic improvements in response to treatments. In addition to autonomic 
dysfunction, the profound and chronic physical inactivity that often occurs after SCI may 
further increase the risk of cardiovascular-related morbidity. Recent work has shown that 
left ventricular diastolic function may be impaired in those with SCI10, which warrants 
further investigation as this could be an early sign of further cardiac impairments. 
However, it is quite possible that the purported diastolic impairments following SCI are 
related to autonomic and/or hemodynamic disturbances rather than ventricular stiffness. 
If so, this would suggest that the left ventricle is healthy in individuals with SCI and that 
these diastolic impairments are a result of extra-ventricular factors, not ventricular 
impairment per se. Therefore, autonomic and hemodynamic interaction with left 
ventricular diastolic function must be further examined in individuals with SCI.  
Summary of Findings: 
 
Results from chapter 4 demonstrated that the QT-variability index (QTVI) is a 
valid estimate of cardiac parasympathetic and sympathetic activity in individuals with 
SCI. Regarding the former, results from the study suggest that the QTVI may be 
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inversely associated with cardiac vagal activity during resting conditions. This was 
shown as QTVI values significantly increased from resting baseline values after 
administering a cholinergic blockade with Atropine. The increase in QTVI after 
parasympathetic blockade was accounted for by a reduction in RR-interval variability, 
suggesting that parasympathetic influence on the QTVI is executed indirectly via heart 
rate variability (HRV). In other words, the parasympathetic system increases beat-by-beat 
depolarization variability by decreasing the amount of temporal variability between each 
beat. Moreover, results also show that the QTVI may be directly associated with cardiac 
sympathetic outflow but only during times of elevated sympathetic activity. This was 
shown as the QTVI significantly increased from baseline when participants performed a 
stress inducing cardiovascular maneuver (head-up tilt and hand submerged in ice cold 
water). Further, the QTVI returned back to baseline values when the β-blocker 
propranolol was administered during the elevated sympathetic state (head-up tilt and hand 
submerged in ice cold water). In contrast to the parasympathetic modulation of the QTVI, 
sympathetic regulation of the QTVI seems to be executed via direct myocardial 
stimulation by increasing myocardial repolarization variability. This was evidenced by a 
significant increase in QT-interval variance, which accounted for the elevation in the 
QTVI. These results are in direct agreement with invasive animal studies that showed the 
QTVI to be inversely related to integrated vagal nerve activity, and that it is modulated 
by HRV during resting conditions11. Our findings also agree with previous animal work 
that showed the QTVI to be directly associated with integrated left stellate ganglionic 
nerve activity and directly modulated via QT-interval variability11.  
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Results from chapter 5 demonstrate that the QTVI has very good day-to-day 
reproducibility in individuals with SCI. This held true for all of the participants as a 
whole, but also for those with injury levels above T4 who may have more severe cardiac 
autonomic impairments. Similar high reproducibility was also shown for the QTVI-apex, 
which is a method of analyzing the QTVI that may be subjected to less external noise. 
The reproducibility values obtained from this study were higher than those previously 
reported from HRV methods12.  
Results from chapter 6 demonstrate that there is a disconnect between cardiac 
parasympathetic activity and left ventricular diastolic function as well as heart rate (HR) 
in individuals with SCI. At baseline, able-bodied individuals showed strong correlations 
between early diastolic filling and various indices of cardiac parasympathetic activity, 
which included HRV and the QTVI. This relationship however, was absent in individuals 
with SCI. Furthermore, an increase in cardiac vagal activity, via the cold face test (CFT), 
resulted in bradycardia and was associated with increased early diastolic filling in able-
bodied individuals. In contrast, the CFT and resultant increase in cardiac vagal activity in 
the SCI group resulted in an atypical chronotropic and diastolic response, which included 
no change in HR and reduced diastolic function, as shown by a reduction in early 
diastolic filling and prolongation of diastolic filling deceleration time.  
Results from chapter 7 show that, unlike recently published findings10, diastolic function 
is not impaired in individuals with SCI. Perhaps more interestingly, individuals with SCI 
were able to maintain normal diastolic function despite being hypovolemic. Although 
reduced preload is typically associated with attenuated diastolic function in the able-
bodied literature13, the SCI group in our study was likely able to maintain diastolic 
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velocities by having a smaller ventricular size, which maintained ventricular wall stress 
and the mass to volume ratio14,15. This was shown in the study as the SCI group did 
demonstrate reduced diastolic function after adjusting for ventricular diameter. In 
addition, both the SCI and able-bodied groups demonstrated similar degrees of diastolic 
velocity augmentations in response to rapid saline infusion, further strengthening the 
notion that diastolic function is normal in those with SCI and that their ventricles are 
highly compliant. 
Implications, Limitations and Future Directions: 
 
The first two studies of this thesis complement each other as they examine the 
validity and the reliability of the QTVI as a novel method of cardiac autonomic 
assessment. Non-invasive measures of autonomic function are of significant clinical 
value, as they may provide diagnostic and prognostic information on autonomic 
regulation, and may also predict the risk for future cardiac events. The results of the first 
two studies suggest that the QTVI may have the ability to reflect both autonomic limbs in 
individuals with autonomically incomplete SCI. This has substantial value to it, as the 
currently used non-invasive measures of cardiac autonomic activity, specifically HRV 
and non-linear HRV, only reflect parasympathetic regulation. There was no valid index 
of cardiac sympathetic activity until the QTVI, and our study confirms that. However, 
before the QTVI can be used in a clinical setting or in more physiological research, more 
studies are warranted to further elucidate its place in the autonomic arena. Firstly, if the 
QTVI is to be used as a gauge of autonomic function, a large scale study is required to 
determine “normal” and “abnormal” QTVI values. This is due to the fact that to date the 
only way to determine if one has an abnormal QTVI value is by making a direct 
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comparison to someone who is considered healthy. Therefore, determining normal 
healthy ranges for QTVI and possibly stratifying them more broadly according to 
autonomic function and or/risk level is required.  
The major limitation to the validity study was undoubtedly the small sample size, 
as we are basing our conclusions from a sample of only 4 individuals with SCI. In 
addition, all of the participants had incomplete tetraplegia, therefore, we do not know if 
those with complete injuries would show similar results. This generalization is further 
compromised by evidence suggesting that low thoracic injuries may result in a constantly 
heightened sympathetic tone due to increased cardiac sympathetic nerve arborisation9. 
Therefore, it is unknown if the QTVI would be a valid measure of cardiac 
parasympathetic activity at rest in individuals with SCI who have different levels and 
severities of injury than those who were tested in our work. Furthermore, it is 
conceptually difficult to employ one value for two outcome measures (in this case 
parasympathetic and sympathetic activity). For example, if an individual with low 
paraplegia has an elevated QTVI at rest, it is difficult to determine if this elevation is due 
to reduced parasympathetic outflow or augmented sympathetic activity. Therefore, the 
QTVI may be a more clear measure of cardiac autonomics in individuals with preserved 
cardiac autonomic function. However, interpreting QTVI values for individuals with 
autonomic imbalances may be difficult at the moment. Accordingly, the first 2 studies of 
this thesis provide a strong foundation for the QTVI as an autonomic assessment tool. 
However, according to the aforementioned limitations, we think that the QTVI still needs 
further investigation in order to truly understand its efficacy as a tool for autonomic 
assessment in SCI.    
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The finding from the third study of a blunted HR response to cardiac vagal 
activity has been shown before in those with SCI7,16 however we further demonstrated 
that individuals with SCI may also display reduced diastolic function in response to 
increased cardiac vagal activity. It is counter-intuitive and likely incorrect to infer that 
elevated vagal activity is detrimental to ventricular function in those with SCI, especially 
since there is substantial evidence that elevated cardiac parasympathetic activity reduces 
the risk for cardiovascular disease and may be cardioprotective17. Instead, the findings 
from our study may shed some light on a potentially under-reported cardiac 
maladaptation to SCI. Specifically, there may be an alteration in cholinergic receptor 
handling of acetylcholine. It is clear from our findings that the CFT did result in some 
elevation in HRV in those with SCI, which is assumed to be a reflection of increased 
acetylcholine uptake by the heart. However, the resultant atypical chronotropic and 
mechanical responses to this cholinergic uptake urge us to hypothesize that the receptors 
may not be functioning correctly, thus resulting in abnormal cardiac responses to vagal 
activity. However, since the methodologies used in this study are quite non-invasive, we 
are limited to speculation. Therefore, further studies are required to determine the source 
of physiological impairments that result in the altered cardiac responses to vagal activity 
in individuals with SCI.  
The results from the final study show strong evidence for normal diastolic 
function and compliant left ventricles in individuals with SCI. Although animal studies 
have shown elevated ventricular fibrosis in rats with SCI18 this was clearly not the case in 
the present work in humans. In addition, this study was the first to show that the left 
ventricle of those with SCI is able to sufficiently and rapidly expand without elevations in 
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filling pressure. Furthermore, although there were only 13 individuals with SCI in the 
study, participants ranged from complete to incomplete injuries, and none demonstrated 
atypical diastolic responses to the saline infusion.  Regarding the recent human studies 
that showed reduced diastolic function following SCI10, it is important to note that the 
diastolic values reported from these individuals were not clinically pathological, but only 
lower than their able-bodied counterparts. This does not necessarily mean that those 
individuals have diastolic dysfunction, but a normal reduction in diastolic velocities that 
is typically associated with physical inactivity. In addition, the participants from the 
current study were active, as they participated in weekly mild-to-moderate exercise. 
Therefore, it seems that SCI per se does not impair diastolic function, but rather it may be 
the accompanying inactivity that causes such deficits. This is encouraging as exercise 
may prevent or reverse such inactivity-induced diastolic impairments in those with SCI. 
However, more invasive studies that employ techniques such as pulmonary wedge 
capillary pressure or even analysis of cardiac biopsies may be warranted to confirm our 
results.   
Final Statement: 
 
The overall theme of this thesis can be broken down into three sub-categories in 
individuals with SCI: autonomic assessment, left ventricular diastolic function and 
autonomic-diastolic interaction. This thesis has provided evidence for normal left 
ventricular mechanical relaxation in those with SCI, in other words, the intrinsic factors 
that govern mechanical ventricular filling, such as ventricular compliance and elasticity, 
are preserved. However, external factors that normally modulate diastolic function, such 
as cardiac parasympathetic activity, may not be able to do so properly after SCI. As 
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mentioned in the introductory statements of this thesis, for normal cardiovascular 
function to be executed, all internal and external factors are required to operate 
synergistically in a harmonious fashion. If one aspect of the cardiovascular system is 
impaired, this will lead to maladaptive changes that may cause further cardiovascular 
degradation. Although we show atypical diastolic-autonomic interactions in those with 
SCI, we could not have done it in a comprehensive manner without validating the QTVI 
as a measure of cardiac autonomic function. Although we employed HRV measures in 
our studies to assess cardiac-autonomic interactions, the QTVI seems to be a more 
rigorous measure of cardiac autonomics19, and therefore, we were able to show, with 
confidence, a disconnect between parasympathetic and diastolic function. Furthermore, 
for the first time, we also showed that the QTVI is a valid measure of cardiac sympathetic 
activity. This marks a turning point in the field, because the literature regarding 
autonomic physiology after SCI has largely been limited to due to the inability to 
correctly measure cardiac sympathetic activity. Therefore, the results from this thesis can 
also possibly facilitate future studies to examine sympathetic and diastolic interactions 
following SCI. More importantly, the implications of this thesis go beyond the scope of 
SCI, as many other populations experience autonomic neuropathies that could impair 
cardiac function. As such having a valid measure of autonomic function can be of benefit 
to many other clinical populations.   
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Appendix A: ASIA Impairment Scale 
 
AIS A: No senory or motor function is preserved in the sacral segments S4-S5 
AIS B: Sensory but no motor function is preserved below the neurological level and 
includes the sacral segments S4-S5 
AIS C: Sensory and motor function is preserved below the neurological level (including 
S4-S5), and more than half of the key muscles below the neurological level have a 
muscle grade less than 3 
AIS D: Sensory and motor function is preserved below the neurological level (including 
S4-S5), and at least half of the key muscles below the neurological level have a muscle 
grade greater than or equal to 3 
AIS E: Normal sensory and motor function  
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Appendix B: Neurological Examination for Spinal Cord Injury 
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Appendix C: Motor Examination 
 
10 myotomes of the left and right sides of the body: 
C5 Elbow Flexors    L2 Hip Flexors 
C6 Wrist Extensors    L3 Knee Extensors 
C7 Elbow Extensors   L4 Ankle Dorsi Flexors 
C8  Finger Flexors    L5  Big Toe Extensors 
T1 Finger Abductors   S1 Ankle Plantar Flexors 
 
Strength Grading Scale: 
0 Total paralysis  
1 Palpable or visible contraction 
2 Active movement with full ROM, gravity eliminated  
3 Active movement with full ROM, against gravity 
4 Active movement with full ROM, against moderate resistance 
5 (normal) active movement with full ROM, against full resistance 
NT    Not testable 
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Appendix D: Sensory Testing: 
 
0/2 Can’t sense contact 
 
1/2 Can distinguish sharp from dull, but the intensity is different compared to reference 
(cheek) 
 
2/2 Can distinguish sharp from dull 
 
 
